Document:

EXHIBIT 10.1

 Exhibit 10.1 
  
 EXECUTION VERSION 
  
 

 
  
 SAVVIS COMMUNICATIONS
CORPORATION 
  

  
 AMENDED AND RESTATED SECURITIES 
 PURCHASE AGREEMENT 
  

  
 February 9, 2004 

 AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT, dated as of February 9, 2004 (this
“Agreement”), by and among SAVVIS COMMUNICATIONS CORPORATION, a Delaware corporation (the “Company”) WELSH, CARSON, ANDERSON & STOWE VIII, L.P., a Delaware limited partnership (“WCAS VIII”), and
the several other entities and individuals affiliated with WCAS VIII listed under “WCAS Affiliates” on Annex I hereto (collectively with WCAS VIII, the “WCAS Purchasers”), Constellation Venture Capital II, L.P., a
Delaware limited partnership (“Constellation Venture”), Constellation Venture Capital Offshore II, L.P., a Cayman Islands limited partnership (“Constellation Venture Offshore”), The BSC Employee Fund IV, L.P., a
Delaware limited partnership (“BSC”) and CVC II Partners, L.L.C., a Delaware limited liability company (collectively with Constellation Venture, Constellation Venture Offshore and BSC, the “Constellation
Purchasers”), Oak Hill Special Opportunities Fund, L.P., a Delaware limited partnership (“Special Opportunities”), Oak Hill Special Opportunities Fund (Management), L.P., a Delaware limited partnership (“Special
Opportunities Management”), WFC Holdings Corporation, a Delaware corporation (“WFC”), Oak Hill Securities Fund, L.P., a Delaware limited partnership (“Oak Hill Securities”), Oak Hill Securities Fund II,
L.P., a Delaware limited partnership (“Oak Hill Securities II”), Lerner Enterprises, L.P., a Maryland limited partnership (“Lerner Enterprises”), P&PK Family Ltd. Partnership, an Oregon partnership
(“P&PK”), Cardinal Investment Partners I, L.P., a Delaware limited partnership (“Cardinal Investment”), Oak Hill Credit Alpha Fund, L.P., a Delaware limited partnership (“Alpha”), Oak Hill
Credit Alpha Fund (Offshore), Ltd., an entity formed under the laws of the Cayman Islands (“Alpha Offshore”), Oak Hill Advisors, L.P., a Delaware limited partnership (“Oak Hill Advisors”), Cardinal Fund I, L.P., a
Delaware limited partnership (“Cardinal”) and FW Savvis Investors, L.P., a Delaware limited partnership (collectively with Special Opportunities, Special Opportunities Management, WCF, Oak Hill Securities, Oak Hill Securities II,
Lerner Enterprises, P&PK, Cardinal Investment, Alpha, Alpha Offshore, Oak Hill Advisors and Cardinal, the “Oak Hill Purchasers”), and the other purchasers that become party to this Agreement in accordance with Section 8.14 (the
“Other Purchasers” and collectively with the WCAS Purchasers, the Constellation Purchasers and the Oak Hill Purchasers, the “Purchasers”). 
  
 WHEREAS, Savvis Asset Holdings, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company
(“Acquisition Subsidiary”) has entered into that certain Asset Purchase Agreement, dated as of January 23, 2004, as amended by Amendment No. 1 thereto, dated as of January 23, 2004 (the “Acquisition Agreement”),
with Cable & Wireless USA, Inc. (“CWUSA”), and Cable & Wireless Internet Services, Inc. (“CWIS”) and together with CWUSA, CWIS and certain of their subsidiaries, “Sellers”) relating to the
sale by Sellers to Acquisition Subsidiary of the Acquired Assets (as defined in the Acquisition Agreement) of Sellers (the “Acquisition”); 
  
 WHEREAS, the United States Bankruptcy Court for the District of Delaware approved the Sale Order (as defined in the Acquisition Agreement) on January 23,
2004; 
  
 WHEREAS, in connection with consummating the Acquisition
Subsidiary’s obligations under the Acquisition Agreement, the Company desires to sell to each Purchaser, and each Purchaser desires to purchase from the Company, on the terms and subject to the conditions set forth herein, the principal amount
of Series A Subordinated Notes of the Company set forth opposite each such Purchaser’s name on Annex I hereto, in substantially the form of Exhibit A hereto (together with the notes to be issued as payment-in-kind interest
thereunder, the “Notes”); 

 WHEREAS, as a further inducement to each Purchaser’s purchase of Notes, the Company will issue to
each Purchaser warrants (“Warrants”) to purchase that number of shares of the Company’s Series B Convertible Preferred Stock, $.01 par value per share (“Series B Stock”) set forth opposite each such
Purchaser’s name on Annex I (“Warrant Shares”), in substantially the form of Exhibit B hereto, which such Warrant Shares shall be convertible into shares of the Company’s common stock, $.01 par value per
share (“Common Stock”) on the terms and conditions set forth in the Certificate of Designations for Series B Convertible Preferred Stock attached hereto as Exhibit C; 
  
 WHEREAS, as a further inducement to each Purchaser’s purchase of Notes,
the Company has agreed to grant to each such Purchaser certain rights pursuant to an amended and restated registration rights agreement among the Company and the investor parties thereto, substantially in the form of Exhibit D attached
hereto, (the “Registration Rights Agreement”) including registration rights with respect to the shares of Common Stock to be received upon conversion of the Warrant Shares (the “Conversion Shares”); 
  
 WHEREAS, the Company is party to that certain Amended and Restated Master
Loan Agreement No. 6857500, dated as of March 8, 2002, among the Company, the other lessor parties signatory thereto and General Electric Capital Corporation (“GECC”) (the “Lease”); 
  
 WHEREAS, in connection with the consummation of the transactions contemplated
by this Agreement and as required under the Lease or by GECC in connection with the Lease, (i) the Company and GECC have agreed to enter into a Consent and Waiver (the “Consent and Waiver”), dated January 16, 2004, as amended and
restated as of the date hereof, and (ii) the Company, certain affiliates of the Company, and each Purchaser have agreed to enter into a Subordination and Intercreditor Agreement with GECC substantially in the form attached hereto as Exhibit E
(the “Subordination Agreement”); 
  
 WHEREAS, in
connection with the Acquisition, the Company expects Acquisition Subsidiary to enter into the sale and leaseback of certain properties constituting Acquired Assets (as defined in the Acquisition Agreement) (the “Sale-Leaseback
Transaction”); and 
  
 WHEREAS, the parties hereto (other
than the Oak Hill Purchasers) entered into a Securities Purchase Agreement dated January 30, 2004 and an Amended and Restated Securities Purchase Agreement dated February 6, 2004 (the “Existing Agreement”); and 
  
 WHEREAS, the parties hereto desire to amend and restate the Existing
Agreement to provide for (i) the addition of the Oak Hill Purchasers as party thereto and (ii) certain changes to the terms under which such Warrants and the Notes are issued. 
  
 NOW, THEREFORE, in consideration of the mutual promises, representations, warranties, covenants and conditions set forth in
this Agreement, the parties hereto agree to amend and restate the Existing Agreement as follows: 
  

 2 

 ARTICLE I 
  

AUTHORIZATION AND SALE OF THE NOTES. 
  
 Section 1.01. Authorization. The Company has authorized the sale and issuance of the Notes, Warrants, Warrant Shares and Conversion Shares
pursuant to the terms of this Agreement. 
  
 Section 1.02.
Sale of Notes and Warrants. 
  
 (a) On the Initial
Closing Date (as defined in Section 1.03(a)), and on the terms and subject to the satisfaction of the applicable conditions set forth in this Agreement, the Company shall issue and sell to each Purchaser, and each Purchaser shall, severally and not
jointly, purchase from the Company the principal amount of the Notes and the number of Warrants set forth opposite such Purchaser’s name in Part I of Annex I for the purchase price (the “Purchase Price”) set forth
therein under “Aggregate Purchase Price.” 
  
 (b) On the
Subsequent Closing Date (as defined in Section 1.03(b)) and on the terms and subject to the satisfaction of the applicable conditions set forth in this Agreement, the Company shall issue and sell to each Purchaser and each Purchaser shall, severally
and not jointly, purchase from the Company the principal amount of the Notes and the number of Warrants set forth opposite such Purchaser’s name in Part II of Annex I for the Purchase Price set forth therein under “Aggregate
Purchase Price.” 
  
 (c) Notwithstanding anything to the
contrary contained herein, the principal amount of Notes otherwise required to be purchased by the WCAS Purchasers at the Subsequent Closing shall be reduced (as determined by WCAS VIII) to the extent of the funds actually received by the Company in
connection with the Sale-Leaseback Transaction on or prior to the Subsequent Closing. Annex I will be adjusted to reflect such reductions. 
  
 (d) The Purchasers and the Company hereby acknowledge and agree that the Notes issued hereunder are part of an “investment unit” that includes
the Warrants issued hereunder. The Purchasers and the Company hereby further acknowledge and agree that, for United States federal income tax purposes (and for purposes of comparable state and local income tax laws), the aggregate fair market values
of the Notes and the Warrants issued in connection with the Initial Closing and the Subsequent Closing shall be mutually agreed upon by WCAS VIII and the Company and the determination of such aggregate fair market values shall take into account all
reasonable factors customarily used in the determination of value of similarly situated securities. The “original issue discount” (as defined by section 1273(a)(1) of the Internal Revenue Code of 1986, as amended) that will accrue on the
Notes (taking into account interest payable on the Notes other than “qualified stated interest” within the meaning of Treasury Regulations Section 1.1273-1(c)) will be mutually agreed upon by WCAS VIII and the Company and will be derived
from the fair market value determination set forth above. None of the parties shall take any position in its tax returns or other informational statements that is inconsistent with any of the foregoing. 
  

 3 

 Section 1.03. Closings; Deliveries. 
  
 (a) Initial Closing. The initial closing of the purchase and sale of
Notes and Warrants (the “Initial Closing”) shall take place on the date hereof, or as promptly as practicable on or after the date hereof, at 10:00 a.m. New York time at the offices of Ropes & Gray LLP at 45 Rockefeller Center,
New York, New York 10111, or at such other time and place as the Company and WCAS VIII may agree, provided that all of the conditions to the Initial Closing herein shall have been satisfied or waived (the date of the Initial Closing, the
“Initial Closing Date”). The Initial Closing may be accomplished by facsimile transmission to the respective offices of counsel for the parties hereto of the requisite documents, duly executed where required, with originals to be
delivered by overnight courier service on the next business day following the Initial Closing Date. 
  
 (b) Subsequent Closing. The subsequent closing of the purchase and sale of Notes and Warrants (the “Subsequent Closing”) shall
take place at 10:00 a.m. at the offices of Ropes & Gray LLP at 45 Rockefeller Center, New York, New York 10111, on the date that is the earlier to occur of the Closing (as defined in the Acquisition Agreement) and the Regulatory Escrow Closing
(as defined in the Acquisition Agreement) or at such other time and place as the Company and WCAS VIII may agree, provided that all of the conditions to the Subsequent Closing herein shall have been satisfied or waived (the date of the Subsequent
Closing, the “Subsequent Closing Date” and, together with the Initial Closing Date, a “Closing Date”). The Subsequent Closing may be accomplished by facsimile transmission to the respective offices of counsel for
the parties hereto of the requisite documents, duly executed where required, with originals to be delivered by overnight courier service on the next business day following the Subsequent Closing Date. 
  
 (c) Closing Deliveries. At the Initial Closing and the Subsequent
Closing, subject to the terms and conditions hereof, the Company will deliver to each Purchaser a Note or Notes and a Warrant or Warrants, executed by the Company in such denominations and amounts and in such name or names as such Purchaser may
designate by notice to the Company, dated the date of the Initial Closing or the Subsequent Closing, as applicable, against payment of the Purchase Price therefor by wire transfer in immediately available funds to an account specified by the
Company. Such Purchase Price paid at the Closing shall be delivered and accepted as full and complete payment against the Notes and the Warrants. 
  
 (d) Use of Proceeds. The proceeds of the sale by the Company of the Notes and Warrants shall be used solely (i) to fund the Acquisition, (ii) to
fund the on-going operational and working capital requirements of Acquisition Subsidiary, (iii) to fund any working capital or capital expenditure requirements of the Company related to the Acquired Assets or caused by the Asset Acquisition, (iv) to
pay all fees and expenses incurred by the Company and the Acquisition Subsidiary in connection with the Acquisition and the issuance of the Notes and Warrants, (v) prior to the consummation of the Acquisition, fund the business of the Acquired
Assets as contemplated by Amendment No.1 to the Acquisition Agreement, (vi) to pay in cash additional purchase price in connection with the acquisition of the assets of WAM!NET, Inc. and (vii) for reserves by the Company (in its reasonable judgment)
in respect of contingencies relating to or arising out of the Acquisition Agreement or the failure of the Acquisition to be consummated. The Company agrees that the funding contemplated by clauses 
  

 4 

 (i) through (v) above will be provided by the Company to the Acquisition Subsidiary as a senior secured intercompany loan
(secured by a first priority lien on all of the assets of the Acquisition Subsidiary). No portion of the proceeds of the sale of the Notes and Warrants hereunder shall be used, directly or indirectly, for the purpose, whether immediate, incidental
or ultimate, of buying or carrying any “margin stock” within the meaning of any regulation, interpretation or ruling of the Board of Governors of the Federal Reserve System, all as from time to time in effect, refunding of any indebtedness
incurred for such purpose, or making any investment prohibited by foreign trade regulations. Without limiting the foregoing, the Issuers agree that in no event shall any proceeds of the sale of the Notes and Warrants hereunder be used in any manner
which might cause the Notes and Warrants or the application of such proceeds to violate any of Regulations T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of the Board of Governors of the Federal Reserve
System, or to violate the Securities Exchange Act of 1934, as amended (the “Exchange Act”), each as in effect as of the Closing and as of such use of the proceeds. 
  
 (e) Financial Advisory Fee. On the applicable Closing Date, the Company shall execute and deliver a financial
advisory services agreement and, on the Subsequent Closing Date, shall pay to the Purchasers or their designees an amount equal to 1% of the principal amount of the Notes purchased by such Purchasers (the “Financial Advisory Fee”).

  
 ARTICLE II 
  
 REPRESENTATIONS AND WARRANTIES OF THE COMPANY 
  
 The Company represents and warrants to each Purchaser as of the date hereof
and on each of the Initial Closing Date and the Subsequent Closing Date, as follows: 
  
 Section 2.01. Organization and Qualification. The Company is a corporation validly existing and in good standing under the laws of the State of Delaware and has all requisite corporate power and
authority to own or lease and operate its properties and assets and to carry on its business as it is now being conducted. The Company is duly qualified as a foreign corporation to do business, and is in good standing, in each jurisdiction in which
the character of its properties owned or leased or the nature of its activities makes such qualification necessary, except where the failure to be so qualified would not have a material adverse effect on the properties, assets, financial condition,
operating results, business or prospects of the Company and its Subsidiaries (as defined in Section 2.02), taken as a whole (a “Material Adverse Effect”). 
  
 Section 2.02. Subsidiaries. Except for the Subsidiaries disclosed in the Company SEC Filings (as defined in
Section 2.08) or as set forth in Schedule 2.02 of the Disclosure Letter of the Company, dated the date hereof (the “Disclosure Letter”), the Company does not own, beneficially or of record, any capital stock or other ownership
interest in any other Person. Savvis Asset Holdings, Inc., a Delaware corporation is a corporation validly existing and in good standing under the laws of Delaware. SAVVIS Communications Corporation, a Missouri corporation (“SAVVIS
Missouri”) is a corporation validly existing and in good standing under the laws of Missouri. Global Network Assets, LLC, a Delaware limited liability company (“Global LLC”), is a limited liability company, duly formed,
validly existing and in good standing under the laws of Delaware. Savvis Procurement Corporation, a Delaware 
  

 5 

 corporation (“Savvis Procurement”), is a corporation validly existing and in good standing under the
laws of Delaware. Each of Acquisition Subsidiary, SAVVIS Missouri, Global LLC and Savvis Procurement has all requisite power and authority to own or lease and operate its properties and assets and to carry out its business as it is now being
conducted. Each of Acquisition Subsidiary, SAVVIS Missouri, Global LLC and Savvis Procurement is duly qualified as a foreign corporation to do business, and is in good standing, in each jurisdiction in which the character of its properties owned or
leased or the nature of its activities makes such qualification necessary, except where the failure to be so qualified would not have a Material Adverse Effect. As used in this Agreement, (i) “Person” means any corporation,
partnership, limited liability company, trust, joint venture or other entity and (ii) ”Subsidiary” means, with respect to any Person, any corporation, association or other business entity of which more than 50% of the total voting
power of shares of capital stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by such Person or one or
more of the other Subsidiaries of such Person or a combination thereof. Acquisition Subsidiary, SAVVIS Missouri, Global LLC and Savvis Procurement are the Company’s only Significant Subsidiaries (as defined in Rule 1-02(w) of Regulation S-X).

  
 Section 2.03. Capitalization. (a) As of the date
hereof, the authorized capital stock of the Company consists of 900,000,000 shares of Common Stock and 50,000,000 shares of Preferred Stock, $.01 par value (“Preferred Stock”). As of the date hereof, 97,708,102 shares of Common
Stock and 203,070 shares of Preferred Stock are issued and outstanding. All outstanding shares of Common Stock have been duly authorized and validly issued and are fully paid and non-assessable. 
  
 (b) As of the date hereof, except for options granted
pursuant to the Company’s stock option plans (the “Stock Option Plans”) to purchase an aggregate of 37,281,834 shares of Common Stock, and except as set forth on Schedule 2.03(b) of the Disclosure Letter, no
subscription, warrant, option, convertible security, stock appreciation or other right (contingent or other) to purchase or acquire any shares of any class of capital stock of the Company or any of its Subsidiaries is authorized or outstanding, and
(except as otherwise expressly contemplated by this Agreement) there is not any commitment of the Company or any of its Subsidiaries to issue any shares, warrants, options or other such rights or to distribute to holders of any class of its capital
stock, any evidences of indebtedness or assets. 
  
 Section 2.04. Authorization of Agreements, etc. (a) Except as set forth on Schedule 2.04 of the Disclosure Letter, the Company has the corporate power and authority to execute, deliver and perform its obligations under
this Agreement and the Registration Rights Agreement. Except as set forth on Schedule 2.04 of the Disclosure Letter, each of (i) the execution and delivery by the Company of this Agreement and the Registration Rights Agreement and the
performance by the Company of its obligations hereunder and thereunder and (ii) the issuance, sale and delivery by the Company of all of the Warrant Shares pursuant to the terms of the Warrants, will be duly authorized prior to the Initial Closing
by all requisite corporate and stockholder action and will not violate any provision of applicable law, any order of any court or other agency of government, the Certificate of Incorporation or 
  

 6 

 Bylaws of the Company, or any provision of any indenture, agreement or other instrument to which the
Company or any of its Subsidiaries or their properties or assets is bound, or conflict with, result in a breach of or constitute (with due notice or lapse of time or both) a default, or result in the vesting, acceleration or material modification of
any benefits under any such indenture, agreement or other instrument or any compensation agreement or benefit plan, or result in the creation or imposition of any liens, claims, charges, restrictions, rights of others, security interests, prior
assignments or other encumbrances in favor of any third Person upon any of the assets of the Company or any of its Subsidiaries. 
  
 (b) Except as set forth on Schedule 2.04 of the Disclosure Letter, the issuance, sale and delivery of the Notes and Warrants to the
Purchasers hereunder are not subject to any preemptive rights of stockholders of the Company or to any right of first refusal or other similar right in favor of any Person. 
  
 (c) Except as set forth on Schedule 2.04 of the Disclosure Letter, the Warrant Shares, when issued in
accordance with the terms of this Agreement and the Warrants, will be duly authorized, validly issued, fully paid and nonassessable shares of capital stock of the Company. Except as set forth on Schedule 2.04, the issuance, sale and delivery
of the Warrant Shares upon exercise of the Warrants will not be subject to any preemptive rights of stockholders of the Company or to any right of first refusal or other similar right in favor of any Person. 
  
 Section 2.05. Validity. This Agreement has been duly executed
and delivered by the Company and constitutes the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms. The Registration Rights Agreement when executed and delivered by the Company in
accordance with this Agreement will constitute the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except that no representation is made as to (i) the enforceability of the
indemnification or contribution provisions of the Registration Rights Agreement and (ii) the enforceability of this Agreement or the Registration Rights Agreement to the extent that their enforceability may be subject to applicable bankruptcy,
insolvency, reorganization, moratorium or similar laws affecting enforceability of creditors’ rights generally or by general equitable principles. 
  
 Section 2.06. Governmental Approvals; Consents. Subject to the accuracy of the representations and warranties of the Purchasers set forth in
Article III and except for (i) any required filing and approval under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, (the “HSR Act”), (ii) the filing with the Secretary of State of Delaware the Certificate of
Designations of Series B Convertible Preferred Stock in the form of Exhibit C, (iii) the filing with the Secretary of State of Delaware of an amendment to the Certificate of Incorporation of the Company to increase the authorized number of
shares of Common Stock, and (iv) applicable filings and approvals, if any, required by applicable federal and state securities laws (including the filing with and approval by the SEC of a proxy statement relating to the shareholder approvals set
forth on Schedule 2.04) and listing regulations, no registration or filing with, or consent or approval of, or other action by, any federal, state or other governmental agency, court, instrumentality or securities exchange (each, a
“Governmental Authority”) or any 
  

 7 

 other third person or entity is or will be necessary for the valid execution, delivery and performance of this Agreement,
the Registration Rights Agreement, or the issuance and delivery of the shares of Warrant Shares. 
  
 Section 2.07. Financial Statements. (a) The Company has furnished to the Purchasers the unaudited consolidated balance sheet of the Company
and its subsidiaries as of September 30, 2003 (the “Interim Balance Sheet”) and the related consolidated statements of operations, stockholders’ equity and cash flows for the nine months then ended. All such financial
statements (including but not limited to any related schedules and/or notes) have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) consistently applied and consistent with prior
periods, except for normal year-end adjustments and the absence of footnotes. Such balance sheet fairly presents in all material respects the consolidated financial position of the Company and its subsidiaries as of September 30, 2003, and such
statements of operations, stockholders’ equity and cash flows fairly present in all material respects the consolidated results of operations, stockholders’ equity and cash flows of the Company and its subsidiaries for the nine months ended
September 30, 2003. 
  
 (b) Except as and to the extent (i)
reflected on the Interim Balance Sheet, (ii) incurred since September 30, 2003 in the ordinary course of business consistent with past practice, (iii) set forth on Schedule 2.07(b) of the Disclosure Letter, or (iv) as disclosed in the Company
SEC Filings, neither the Company nor any of its subsidiaries has any material liabilities or obligations of any kind or nature, whether known or unknown, secured or unsecured, absolute, accrued, contingent or otherwise, and whether due or to become
due, that would be required to be reflected on a balance sheet, or the notes thereto, prepared in accordance with GAAP. 
  
 (c) Except as set forth on Schedule 2.07(c) of the Disclosure Letter or as disclosed in the Company SEC Filings (as defined in Section 2.08), since
September 30, 2003, neither the Company nor any of its subsidiaries has suffered any Material Adverse Effect. 
  
 Section 2.08. SEC Filings. The Company has filed all forms, reports and documents required to be filed with the Securities and Exchange
Commission (the “SEC”) since the completion of the Company’s initial public offering on February 18, 2000, and the Company has made available to the Purchaser, as filed with the SEC, complete and accurate copies of (i) the
Annual Report of the Company on Form 10-K for the years ended December 31, 2001 and 2002, and (ii) all other reports, statements and registration statements (including but not limited to Current Reports on Form 8-K and Quarterly Reports on Form
10-Q) filed by the Company with the SEC since December 31, 2002, in each case including but not limited to all amendments and supplements (collectively, the “Company SEC Filings”). The Company SEC Filings (excluding any financial
statements or schedules included therein, which are covered by the representations and warranties of the Company in Section 2.07(a)), (i) were prepared in compliance with the requirements of the Securities Act of 1933, as amended (the
“Securities Act”), or the Exchange Act, and the rules and regulations thereunder, as the case may be, and (ii) did not at the time of filing (or if amended, supplemented or superseded by a filing prior to the date hereof, on the date of
that filing) contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not
misleading. 
  

 8 

 Section 2.09. Absence of Certain Changes or Events. Except as otherwise expressly
contemplated by this Agreement, since September 30, 2003, neither the Company nor any of its Subsidiaries has (a) issued any stock, bonds or other corporate securities, (b) borrowed or refinanced any indebtedness for borrowed money other than
borrowings under the Lease, (c) discharged or satisfied any material claim or incurred or paid any obligation or liability (absolute or contingent) other than current liabilities shown on the Interim Balance Sheet and current liabilities incurred
since the date of such balance sheet in the ordinary course of business consistent with past practice, (d) in the case of the Company only, declared or made any payment or distribution to stockholders, or purchased or redeemed any shares of its
capital stock or other securities, or (e) except in connection with this Agreement and the transactions contemplated hereby, entered into any agreement, letter of intent or similar undertaking to take any of the actions listed in clauses (a) through
(d) above. 
  
 Section 2.10. Actions Pending. Except
as set forth in the Company SEC Filings, there is no action, suit, investigation or proceeding pending or, to the best knowledge of the Company, threatened against or affecting the Company or any of its Subsidiaries to which its or any of its
Subsidiaries’ property is subject, before any court or by or before any governmental body or arbitration board or tribunal, which the Company would be required to disclose pursuant to Item 1 of Part II of Form 10-Q if such Form 10-Q were
required to be filed on and as of the date hereof. For the purposes of this Agreement, the term “best of the knowledge of the Company” shall mean the actual knowledge, upon reasonable inquiry, of the executive officers of the Company.

  
 Section 2.11. Compliance with Law; Permits.
Neither the Company nor any of its Subsidiaries is in material default in any respect under any order or decree of any court, governmental authority, arbitrator or arbitration board or tribunal or under any laws, ordinances, governmental rules or
regulations to which the Company or any of such Subsidiaries or any of their respective properties or assets is subject, except where such default would not have a Material Adverse Effect. The Company possesses all permits, authorizations,
approvals, registrations, variances and licenses (“Permits”) necessary for the Company or its Subsidiaries to own, use and maintain their properties and assets or required for the conduct of its business in substantially the same
manner as it is currently conducted, except where the failure to possess any such Permit would not have a Material Adverse Effect. Except to the extent the failure of any of the following to be correct would not have a Material Adverse Effect, each
Permit is in full force and effect, and no proceeding is pending or, to the best knowledge of the Company, threatened to modify, suspend, revoke or otherwise limit any Permit, and no administrative or governmental actions have been taken or, to the
best knowledge of the Company, threatened in connection with the expiration or renewal of any Permit. 
  
 Section 2.12. Contracts. Except as disclosed in the Company SEC Filings or as set forth on Schedule 2.12(i) of the Disclosure Letter,
there are no contracts or agreements that are material to the conduct of the Company’s business or to the financial condition or results of operations of the Company and its subsidiaries, taken as a whole, that the Company would be 

 

 9 

 required to disclose pursuant to paragraph 10 of Item 601 of Regulation S-K if a Form 10-Q were required to be filed on
and as of the date hereof. Except as set forth in the SEC Filings or on Schedule 2.12(ii) of the Disclosure Letter, each of the agreements (collectively, the “Material Agreements”) disclosed as an exhibit in the Company SEC
Filings in response to paragraph 10 of Item 601 of Regulation S-K under which there are continuing rights or obligations is a valid and enforceable obligation of the Company and, to the best knowledge of the Company, of the other parties thereto,
except where the failure to be valid or enforceable would not have a Material Adverse Effect and provided that no representation is made as to the enforceability of such agreements to the extent that their enforceability may be subject to applicable
bankruptcy, insolvency, reorganization, moratorium or similar laws affecting enforceability of creditors’ rights generally or by general equitable principles. To the best knowledge of the Company, the Company has not been notified in writing of
any claim that any Material Agreement is not valid and enforceable in accordance with its terms for the periods stated therein (other than where such enforceability is in violation of public policy or law), or that there is under any such contract
any existing default or event of default or event that with notice or lapse of time or both would constitute such a default, except any such failure to be valid or enforceable and any such defaults that, in the aggregate, would not have a Material
Adverse Effect. Except for the Financial Services Agreements executed in connection herewith, the Company is not a party to any contract or agreement that would result in an obligation of the Company to make any payments under such agreement or
contract solely as a result of the execution and delivery of this Agreement or the Registration Rights Agreement or the consummation of any of the transactions contemplated hereby or thereby (including, but not limited to, the issuance, sale and
delivery of the Warrant Shares and the Conversion Shares). The Company has heretofore provided true and correct copies of the Material Agreements to the Purchasers. 
  
 Section 2.13. Insurance. The Company maintains insurance with respect to its businesses, properties, officers,
directors and employees customary with industry practices. The Company has heretofore made available for inspection by the Purchaser true and complete copies of all such insurance policies. Such policies are, and will be, on the Closing Date, in
full force and effect and are, and will be upon the Closing, free from any right of termination or limitation other than for non-payment) on the part of the insurance carriers. 
  
 Section 2.14. Offering of the Notes and Warrant. Assuming the accuracy of the representations and warranties
of the Purchasers set forth in Article III hereof, neither the Company nor any Person acting on the Company’s behalf has taken or will take any action (including but not limited to, without limitation, any offer, issuance or sale of any
securities of the Company under circumstances which might require the integration of such transactions with the sale of the Notes and the Warrants under the Securities Act or the rules and regulations of the SEC thereunder) which would require the
offering, issuance or sale of the Notes and the Warrants to the Purchasers (but not including the resale thereof) pursuant to this Agreement to be registered under the Securities Act. 
  
 Section 2.15. Related-Party Transactions. Except (i) as set forth in the Company SEC Filings or (ii) as
contemplated hereby, there are no existing material arrangements or proposed material transactions between the Company and any Person or entity that the Company would be required to disclose pursuant to Item 404 of Regulation S-K of the SEC if a
proxy statement of the Company were required to be filed on or as of the date hereof, other than arrangements or transactions between the Company and any of the Purchasers. 
  

 10 

 Section 2.16. Brokers. All negotiations relative to this Agreement and the transactions
contemplated hereby have been carried on by the Company directly with the Purchasers, without the intervention of any other Person on behalf of the Company in such manner as to give rise to any valid claim by any other Person against the Purchasers
for a finder’s fee, brokerage commission or similar payment. 
  
 ARTICLE III 
  
 REPRESENTATIONS AND WARRANTIES OF
THE PURCHASERS 
  
 The Purchasers, severally and not jointly,
represent and warrant to the Company as of the date hereof and on each of the Initial Closing Date and the Subsequent Closing Date as follows: 
  
 Section 3.01. Organization. Such Purchaser, (other than any Purchaser who is an individual) is duly organized, validly existing and in good
standing under the laws of its jurisdiction of organization and has all requisite corporate, limited liability or limited partnership power and authority to operate its properties and assets and to carry on its business as it is now being conducted.

  
 Section 3.02. Authorization. The execution,
delivery and performance by such Purchaser of this Agreement and the Registration Rights Agreement, and the purchase and receipt by such Purchaser of the Notes and Warrant being acquired by it hereunder, have been duly authorized by all requisite
action on the part of such Purchaser and will not violate any provision of applicable law, any order of any court or other agency of government, the charter or other governing documents of such Purchaser. 
  
 Section 3.03. Validity. This Agreement has been duly executed
and delivered by such Purchaser and constitutes the legal, valid and binding obligation of such Purchaser, enforceable against such Purchaser in accordance with its terms. The Registration Rights Agreement, when executed and delivered in accordance
with this Agreement, will constitute the legal, valid and binding obligation of such Purchaser, enforceable against such Purchaser in accordance with its terms. 
  
 Section 3.04. Investment Representations. 
  
 (a) Such Purchaser is acquiring the Notes and Warrants being purchased by such Purchaser hereunder for such Purchaser’s
own account, for investment, and not with a view toward the resale (subject to the forward purchase contracts between WFC and the Oak Hill Participants) or distribution thereof. 
  
 (b) Such Purchaser understands that it must bear the economic risk of the investment for an indefinite period of time,
because the Notes and Warrants are not, and, when issued upon exercise of the Warrants, the Warrant Shares will not be registered under the 
  

 11 

 Securities Act or any applicable state securities laws and may not be resold unless subsequently registered under the
Securities Act and such other laws or unless an exemption from such registration is available. 
  
 (c) Such Purchaser has the ability to bear the economic risks of the investment in the Notes and the Warrants being purchased hereunder for an indefinite
period of time. Such Purchaser further acknowledges that it has received copies of the Company SEC Filings and has had the opportunity to ask questions of, and receive answers from, officers of the Company with respect to the business and financial
condition of the Company and the terms and conditions of the offering of the Notes and the Warrants and to obtain additional information necessary to verify such information or can acquire it without unreasonable effort or expense.

  
 (d) Such Purchaser has such knowledge and experience in
financial and business matters that such Purchaser is capable of evaluating the merits and risks of its investment in the Notes and the Warrants. Such Purchaser further represents that it is an “accredited investor” as such term is defined
in Rule 501 of Regulation D of the SEC under the Securities Act with respect to its purchase of the Notes and the Warrants, and that such Purchaser has not been formed solely for the purpose of purchasing the Notes and the Warrants. 
  
 Section 3.05. Governmental Approvals; Consents. No registration
or filing with, or consent or approval of, or other action by, any Governmental Authority is or will be necessary by such Purchaser for the valid execution, delivery and performance of this Agreement and the Registration Rights Agreement. 

  
 ARTICLE IV 
  
 COVENANTS OF THE COMPANY 
  
 Section 4.01. Operation of Business. From the date hereof until
the Subsequent Closing Date, except as expressly provided for in this Agreement or as consented to by WCAS VIII in writing, the Company shall not: 
  
 (a) amend its Certificate of Incorporation or bylaws; 
  
 (b) issue any capital stock other than pursuant to this Agreement or other contractual obligations disclosed in Schedule 2.03(b) of the
Disclosure Letter or referred to in Section 2.03(b), or declare or pay any dividend or distribution (whether in cash, stock or property) in respect of its Common Stock; 
  
 (c) take any action, or knowingly omit to take any action, that would, or that would reasonably be expected to, result in
(A) any of the representations and warranties of the Company set forth in Article II becoming untrue, (B) any of the conditions to the obligations of the Purchasers set forth in Section 6.01 not being satisfied, or (C) the operation of the business
of the Company or its Subsidiaries outside the ordinary course of business consistent with past practice; or 
  
 (d) enter into any agreement or commitment to do any of the foregoing. 
  

 12 

 Section 4.02. Access to Information. From the date hereof until the Subsequent Closing
Date, the Company will (a) at the reasonable request of any authorized partner, designee or officer of any Purchaser, permit any such authorized partner, designee or officer, and their representatives, to visit and inspect any of the Company’s
properties and the properties of each of its Subsidiaries, to examine their books of account and records, to make copies and extracts therefrom, to observe the taking of any physical inventories of their properties by them or their accountants, to
discuss their affairs, finances and accounts with, and to be advised as to the same by, their officers and employees, and their independent public accounts, (b) furnish to the Purchasers and their authorized representatives such financial and
operating data and other information relating to the Company and its Subsidiaries as such Persons may reasonably request and (c) instruct its counsel, independent accountants and financial advisors to cooperate with the Purchasers and their
authorized representatives in their investigation of the Company. Any investigation pursuant to this Section shall be conducted in such manner as not to interfere unreasonably with the conduct of the business of the Company. 
  
 Section 4.03. SEC Filings. The Company agrees that it will file
the reports required to be filed by it under the Securities Act and the Exchange Act so long as the Company is registered under the Exchange Act or, if the Company is not required to file any such reports, it shall, upon the written request of WCAS
VIII, make publicly available such information as is necessary to permit sales by the Purchasers pursuant to Rule 144 under the Securities Act of the Conversion Shares. Upon the request of WCAS VIII, the Company will deliver to the Purchasers a
written statement that it has complied with such requirements. 
  
 Section 4.04. Agreement to Take Necessary and Desirable Actions. The Company shall (a) use commercially reasonable best efforts to consummate, as promptly as practicable after the date hereof, the Sale Leaseback Transaction
and (b) use commercially reasonable best efforts to consummate the Acquisition. 
  
 Section 4.05. Compliance with Conditions; Commercially Reasonable Efforts. The Company shall use all commercially reasonable efforts to cause all conditions precedent to the obligations of the Company
and the Purchasers to be satisfied. Upon the terms and subject to the conditions of this Agreement, the Company will use all commercially reasonable efforts to take, or cause to be taken, all action, and to do, or cause to be done, all things
necessary, proper or advisable consistent with applicable laws to consummate and make effective in the most expeditious manner practicable the issuance, sale and delivery of the Notes and the Warrants to the Purchasers in accordance with the terms
of this Agreement. 
  
 Section 4.06. Consents and
Approvals. The Company (a) shall use all commercially reasonable efforts to obtain all necessary consents, waivers, authorizations and approvals of all Governmental Authorities, and of all other Persons required in connection with the execution,
delivery and performance of this Agreement or the Registration Rights Agreement or the consummation of the transactions contemplated hereby or thereby (including, without limitation, obtaining any stockholder approval referred to in Schedule
2.04); and (b) shall diligently assist and cooperate with the Purchasers in preparing and filing all documents required to be submitted by the Purchasers to any Governmental Authority in connection with the issuance, sale and delivery of the
Notes and the Warrants to the Purchasers (which assistance and cooperation shall include timely furnishing to the Purchasers all information concerning the 
  

 13 

 Company and its Subsidiaries that counsel to the Purchasers reasonably determines is required to be included in such
documents or would be helpful in obtaining any such required consent, waiver, authorization or approval). 
  
 Section 4.07. Reservation of Shares. The Company shall at all times after the date hereof and prior to the expiration date of the Warrants
reserve and keep available out of its authorized but unissued shares of Series B Stock and Common Stock, as applicable, for the purpose of effecting the exercise of the Warrants, the conversion of the Warrant Shares into Common Stock and otherwise
complying with terms of this Agreement, such number of its duly authorized shares of Series B Stock and Common Stock as shall be sufficient to effect the exercise of the Warrants from time to time outstanding, to effect the conversion of the Warrant
Shares from time to time outstanding, or otherwise to comply with the terms of this Agreement. The Company shall use reasonable best efforts to obtain any authorization, consent, approval or other action by or make any filing with any court or
administrative body that may be required under applicable state securities laws in connection with the issuance of shares of the Warrant Shares and the Conversion Shares. 
  
 Section 4.08. Listing of Shares. The Company shall use all commercially reasonable efforts to cause the
Conversion Shares to be listed or otherwise eligible for trading on the NASDAQ SmallCap Market or such other exchange or market at which the Common Stock is traded at the time of conversion of the Warrant Shares. 
  
 Section 4.09. Use of Proceeds. The Company shall not use the
aggregate proceeds to be received upon issuance of the Notes and Warrants other than for the purposes set forth in Section 1.03(d) hereof. 
  
 Section 4.10. Restrictions on Performance. 
  
 (a) From the date hereof until the Subsequent Closing Date, without the written consent of WCAS VIII, the Company shall not at any time
enter into an agreement or other instrument limiting in any manner its ability to perform its obligations under this Agreement or the Notes and Warrants issued or to be issued hereunder, or making such performance of the issuance of the Warrant
Shares upon exercise of the Warrant or the Conversion Shares upon conversion of the Warrant Shares a default under any such agreement or instrument. The parties agree and acknowledge that this Section shall not be construed to prohibit the execution
and delivery of the Subordination Agreement as contemplated by this Agreement. 
  
 (b) From the date hereof until the earlier of (i) the date the stockholders of the Company shall have approved the issuance of the
Warrants and the terms of the Warrants, including the issuance of the Warrant Shares and the Conversion Shares (the “Shareholder Approval”) and (ii) the first date after the Subsequent Closing Date that all outstanding Warrants
shall have been exercised, the Company shall not, without the written consent of WCAS VIII, (i) issue any Additional Shares of Common Stock (as defined in the Warrant) without consideration or for a consideration per share less than the Base
Exercise Price (as defined in the Warrant), (ii) subdivide or split the outstanding shares of Common Stock, (iii) combine or reclassify the outstanding shares of Common Stock into a smaller or larger number 
  

 14 

 of shares, (iv) issue by reclassification of the shares of Common Stock any shares of capital stock of
the Company, (v) pay a dividend or make a distribution payable in shares of Common Stock on any class of capital stock of the Company, (vi) distribute to any holders of Common Stock (whether by dividend or in a merger, amalgamation, consolidation or
otherwise) evidences of indebtedness, shares of capital stock of any class or series, other securities, cash or assets in respect of such holder’s Common Stock or (vii) engage in any Fundamental Change (as defined in the Warrant) (it being
understood that each Purchaser shall have the right to consent to any modification to the terms of the Series B Stock made in connection with such Fundamental Change). 
  
 Section 4.11. Stockholders Meeting. The Company shall take all action necessary, in accordance with Delaware
General Corporation Law, its Amended and Restated Certificate of Incorporation, its By-laws and the requirements of the Nasdaq SmallCap Market, to convene a 2004 annual meeting of stockholders as promptly as practicable after the date hereof and
shall submit to its stockholders for consideration at such meeting, a proposal that such stockholders approve to the terms of the transactions contemplated by this Agreement. In connection with its 2004 annual meeting of stockholders, the Company
shall prepare and file with the SEC under the Exchange Act, and shall use reasonable commercial efforts to have cleared by the SEC, and promptly mailed to its stockholders, a proxy statement and form of proxy relating to such meeting. 
  
 Section 4.12. Indebtedness. If the Company or any of its
subsidiaries wishes to create, incur or assume any additional indebtedness for borrowed money (“Indebtedness”) which is senior to or pari passu with the Notes in right of repayment of principal upon a liquidation, insolvency
proceeding or otherwise (“New Debt”), the Corporation shall irrevocably offer each of the entities listed on Annex II hereto (the “Oak Hill Participants”) (subject only to the consummation of the financing) the
right to participate as a lender on the same terms as provided to such lenders in an amount of such New Debt equal to that percentage of the principal amount of such New Debt equal to the percentage of the aggregate principal amount of outstanding
Notes then held by such Oak Hill Participant; provided, that such offer need not be made (i) to refinance the principal amount of Indebtedness already incurred or to be incurred or referred to in agreements to which the Corporation is a party and
which are in effect on the date hereof or (ii) to any single issuance of New Debt in a principal amount equal to or less than $15,000,000. Any Oak Hill Participant may elect to purchase the New Debt offered to an Oak Hill Participant that elected
not to accept the offer. Notwithstanding anything contained herein to the contrary, the Oak Hill Participant shall have no more than five (5) business days to accept any offer made pursuant to the terms of this Section. 
  
 Section 4.13. If the Acquisition Agreement is terminated in accordance
with its terms, (a) the Company will promptly thereafter pay each Purchaser that amount of cash (the “Repayment Amount”) equal to the product of such Purchaser’s pro rata portion (expressed as a percentage) of the aggregate
amount of cash invested in the Company by all of the Purchasers (the “Aggregate Investment Amount”) under this Agreement multiplied by that portion of the Aggregate Investment Amount (i) not theretofore expended by the Company in
accordance with Section 1(d) of this Agreement or otherwise in accordance with the Acquisition Agreement or (ii) not otherwise reserved by the Company (in its reasonable judgment) in respect of contingencies relating to or arising out of the
Acquisition Agreement or the failure of the Closing 
  

 15 

 (as defined in the Acquisition Agreement) to be consummated, and (b) such Purchaser will deliver to the Company for
cancellation the face amount of the Notes and corresponding Warrants (or securities for which the Warrants have been exchanged or into which such securities have been converted, as applicable) equal to the Repayment Amount. 
  
 ARTICLE V 
  
 COVENANTS OF THE PURCHASERS 
  
 Section 5.01. Agreement to Take Necessary and Desirable Actions. Each Purchaser shall (a) subject to the satisfaction of the conditions set
forth in Section 6.01, execute and deliver the Registration Rights Agreement and such other documents, certificates, agreements and other writings and (b) take such other actions, in each case, as may be reasonably necessary, desirable or requested
by the Company in order to consummate or implement the issuance, sale and delivery of the Notes and Warrants to the Purchasers in accordance with the terms of this Agreement. 
  
 Section 5.02. Compliance with Conditions; Commercially Reasonable Efforts. Each Purchaser will use all
commercially reasonable efforts to cause all of the obligations imposed upon it in this Agreement to be duly complied with, and to cause all conditions precedent to the obligations of the Company and the Purchasers to be satisfied. Upon the terms
and subject to the conditions of this Agreement, each Purchaser will use all commercially reasonable efforts to take, or cause to be taken, all action, and to do, or cause to be done, all things necessary, proper or advisable consistent with
applicable law to consummate and make effective in the most expeditious manner practicable the issuance, sale and delivery of the Notes and the Warrants to such Purchaser in accordance with the terms of this Agreement. 
  
 Section 5.03. Consents and Approvals. Each Purchaser (a) shall
use all commercially reasonable efforts to obtain all necessary consents, waivers, authorizations and approvals of all Governmental Authorities, and of all other Persons required in connection with its execution, delivery and performance of this
Agreement or the Registration Rights Agreement, or the consummation of transactions contemplated hereby or thereby and (b) shall diligently assist and cooperate with the Company in preparing and filing all documents required to be submitted by the
Company to any Governmental Authority in connection with such transactions (which assistance and cooperation shall include, without limitation, timely furnishing to the Company all information concerning the Purchaser that counsel to the Company
reasonably determines is required to be included in such documents or would be helpful in obtaining any such required consent, waiver, authorization or approval). 
  
 ARTICLE VI 
  
 CONDITIONS PRECEDENT 
  
 Section 6.01. (a) Conditions Precedent to the Obligations of the Purchasers in connection with the Initial Closing and the Subsequent
Closing. With regard to the Initial 
  

 16 

 Closing and the Subsequent Closing, the obligations of the Purchasers hereunder are, at their option, subject to the
satisfaction of the following conditions: 
  
 (i)
Representations and Warranties to Be True and Correct. The representations and warranties of the Company contained in this Agreement that are qualified as to materiality or Material Adverse Effect shall be true and correct and all other
representations and warranties of the Company shall be true and correct in all material respects, each such Closing Date with the same force and effect as though such representations and warranties had been made on and as of such date. 

 
 (ii) Performance. The Company shall have performed and complied in
all material respects with all agreements, covenants and conditions contained herein required to be performed or complied with by it prior to or on such Closing Date. 
  
 (iii) All Proceedings to Be Satisfactory. All corporate and other proceedings to be taken by the Company and all
waivers and consents to be obtained by the Company in connection with the transactions contemplated hereby shall have been taken or obtained by the Company. 
  
 (iv) Legal Proceedings. On such Closing Date, no preliminary or permanent injunction or other order, decree or ruling issued by any court of
competent jurisdiction nor any statute, rule, regulation or order entered, promulgated or enacted by any governmental, regulatory or administrative agency or authority, or national securities exchange shall be in effect that would prevent the
consummation of the transactions contemplated by this Agreement. 
  
 (v) Registration Rights Agreement. The Company shall have executed and delivered the Registration Rights Agreement. 
  
 (vi) Governmental Approvals. Except as set forth on Schedule 2.04 and except for the expiration or termination of the waiting period under
the HSR Act (“HSR Approval”), all necessary governmental and regulatory consents and approvals and necessary third party consents shall have been obtained or shall have expired, as applicable. 
  
 (vii) No Material Adverse Effect. There shall have been no Material
Adverse Effect since October 30, 2003, the date on which the Company filed its Form 10-Q for the quarter ended September 30, 2003. 
  
 (viii) Opinions of Counsel. In connection with the Initial Closing, the Purchaser shall have received from Hogan & Hartson, L.L.P. and the
Chief Legal Officer of the Company opinions each dated the Initial Closing Date and in form and substance reasonably satisfactory to the Purchaser. In connection with the Subsequent Closing, the Purchaser shall have received from Hogan &
Hartson, L.L.P. and the Chief Legal Officer of the Company opinions each dated the Subsequent Closing Date substantially equivalent to the opinions delivered on the Initial Closing Date. 
  

 17 

 (ix) Consent and Waiver and Subordination Agreement. The Company and GECC shall have executed and
delivered to WCAS VIII the Consent and Waiver and the Subordination Agreement. 
  
 (x) Rights under the Acquisition Agreement. The Company shall not have waived any of its material rights under the Acquisition or exhibits thereto. 
  
 (b) Additional Condition Precedent to the Obligations of the Purchasers in connection with the Subsequent Closing.
All conditions to the consummation of the Closing (as defined in the Acquisition Agreement) or the Regulatory Escrow Closing (as defined in the Acquisition Agreement) other than the payment of the Purchase Price (as defined in the Acquisition
Agreement) shall have been satisfied. 
  
 Section 6.02.
Conditions Precedent to the Obligations of the Company in Connection with the Initial Closing and the Subsequent Closing. With regard to the Initial Closing and the Subsequent Closing, the obligations of the Company hereunder are, at its
option, subject to the satisfaction of the following conditions: 
  
 (a) Representations and Warranties to Be True and Correct. The representations and warranties of the Purchasers contained in this Agreement shall be true and correct in all material respects on such Closing
Date with the same effect as though such representations and warranties had been made on and as of such date. 
  
 (b) Performance. The Purchasers shall have performed and complied in all material respects with all agreements, covenants and
conditions contained herein required to be performed or complied with by them prior to or on the Initial Closing Date and the Subsequent Closing Date, as applicable. 
  
 (c) All Proceedings to Be Satisfactory. All proceedings to be taken by the Purchasers and all waivers
and consents to be obtained by the Purchasers in connection with the transactions contemplated hereby shall have been taken or obtained by the Purchasers and all documents incident thereto shall be satisfactory in form and substance to the Company
and its counsel. 
  
 (d) Legal
Proceedings. On the Closing Date, no preliminary or permanent injunction or other order, decree or ruling issued by any court of competent jurisdiction nor any statute, rule, regulation or order entered, promulgated or enacted by any
governmental, regulatory or administrative agency or authority, or national securities exchange shall be in effect that would prevent the consummation of the transactions contemplated by this Agreement. 
  
 (e) Registration Rights Agreement. The Purchasers
shall have executed and delivered the Registration Rights Agreement. 
  
 (f) Governmental Approvals. Except as set forth on Schedule 2.04 and except for HSR Approval, all necessary governmental approvals and regulatory approvals and necessary third party consents shall have
been obtained or shall have expired, as applicable. 
  

 18 

 (g) Additional Condition Precedent to the Obligations of the Company in connection
with the Subsequent Closing. All of the conditions to the obligations of the Sellers to consummate the Closing (as defined in the Acquisition Agreement) other than the receipt of the Purchase Price (as defined in the Acquisition Agreement) shall
have been satisfied. 
  
 ARTICLE VII 
  
 SURVIVAL OF REPRESENTATIONS; INDEMNITY 
  
 Section 7.01. Survival of Representations. Subject as set forth
below, all representations and warranties made by any party hereto in this Agreement or pursuant hereto shall survive for the period commencing on the date hereof and ending on the first anniversary of the date hereof. 
  
 Section 7.02. General Indemnity. 
  
 (a) Subject to the terms and conditions of this Article, the Company hereby
agrees to indemnify, defend and hold the Purchasers harmless from and against all demands, claims, actions or causes of action, assessments, losses, damages, liabilities, costs and expenses, including, without limitation, interest, penalties and
reasonable attorneys’ fees and expenses (collectively, “Damages”), asserted against, resulting to, imposed upon or incurred by the Purchasers by reason of or resulting from a breach of any representation, warranty or covenant
of the Company contained in or made pursuant to this Agreement. 
  
 (b) Subject to the terms and conditions of this Article VII, the Purchasers hereby agree, severally and not jointly, to indemnify, defend and hold the Company harmless from and against all Damages asserted against, resulting to, imposed
upon or incurred by the Company by reason of or resulting from a breach of any representation, warranty or covenant of such Purchaser contained in or made pursuant to this Agreement. 
  
 Section 7.03. Conditions of Indemnification. The respective several obligations and liabilities of the
Purchasers, on the one hand, and the Company, on the other hand (the “indemnifying party”), to the other (the “party to be indemnified”) under Section 7.02 hereof with respect to claims resulting from the assertion
of liability by third parties shall be subject to the following terms and conditions: 
  
 (a) as soon as reasonably practicable but not later than 20 days after receipt of notice of commencement of any action or the assertion in writing of any claim by a third party, the party to be indemnified shall give
the indemnifying party written notice thereof together with a copy of such claim, process or other legal pleading, and the indemnifying party shall have the right to undertake the defense thereof by representatives of its own choosing; 

 
 (b) in the event that the indemnifying party, by the 30th day after receipt of notice of any such claim (or, if earlier, by the tenth day preceding the day on which an answer or other
pleading must be served in order to prevent judgment by default in favor of the Person asserting such claim), does not elect to defend against such claim, the party to be indemnified will (upon further notice to the indemnifying party) have the
right to undertake the defense, compromise or settlement of such claim on behalf of and for the account and risk of the 
  

 19 

 indemnifying party, subject to the right of the indemnifying party to assume the defense of such claim at any time prior
to settlement, compromise or final determination thereof, provided that the indemnifying party shall be given at least 15 days prior written notice of the effectiveness of any such proposed settlement or compromise; 
  
 (c) anything in this Section 7.03 to the contrary notwithstanding (i) if
there is a reasonable probability that a claim may materially and adversely affect the indemnifying party other than as a result of money damages or other money payments, the indemnifying party shall have the right, at its own cost and expense, to
compromise or settle such claim, but (ii) the indemnifying party shall not, without the prior written consent of the party to be indemnified, settle or compromise any claim or consent to the entry of any judgment which does not include as an
unconditional term thereof the giving by the claimant or the plaintiff to the party to be indemnified a release from all liability in respect of such claim; and 
  

(d) in connection with any such indemnification, the indemnified party will cooperate in all reasonable requests of the indemnifying party. 

 
 ARTICLE VIII 
  
 MISCELLANEOUS 
  
 Section 8.01. Restrictive Legends. Each Note, Warrant, each certificate representing the Warrant Shares, and
each certificate representing the Conversion Shares and any shares of capital stock received in respect thereof, whether by reason of a stock split or share reclassification thereof, a stock dividend thereon or otherwise, and each certificate for
any such securities issued to subsequent transferees of any such certificate shall be stamped or otherwise imprinted with the legends, if any, required to be borne by such securities by the Registration Rights Agreement, except as expressly
otherwise provided in such agreement. 
  
 Section 8.02.
Expenses, etc. The Company shall pay all reasonable out-of-pocket expenses of the WCAS Purchasers, including but not limited to, accountants’ fees, and the reasonable fees and expenses of Ropes & Gray LLP, incurred by the WCAS
Purchasers in connection with the Acquisition, the negotiation and consummation of the transactions contemplated by this Agreement, and the issuance of the Notes and the Warrants hereunder. All costs and expenses incurred by the Company in
connection with this Agreement shall be paid by the Company. 
  
 Section 8.03. Survival of Agreements. All covenants, agreements and representations and warranties (except in the case of representations and warranties, as limited in Section 7.01) made herein shall survive the execution and
delivery of this Agreement, the issuance, sale and delivery of the Notes, the Warrants, the Warrant Shares and the Conversion Shares, notwithstanding any investigation made at any time by or on behalf of any party hereto. All statements contained in
any certificate or other instrument delivered by the Company hereunder shall be deemed to constitute representations and warranties made by the Company. 
  
 Section 8.04. Notices. Any notice or other communications required or permitted hereunder shall be deemed to be sufficient if contained in a
written instrument delivered in person or duly sent by first class certified mail, postage prepaid, by nationally 
  

 20 

 recognized overnight courier, or by facsimile addressed to such party at the address or facsimile number set forth below
or such other address or facsimile number as may hereafter be designated in writing by the addressee to the addressor listing all parties: 
  
 if to the Company, to 
  
 SAVVIS Communications Corporation 
 1 Savvis
Parkway 
 Town and Country, Missouri 63017 
 Fax: 
 Attention: Chief Legal Officer 
  
 with a copy to 
  
 SAVVIS Communications Corporation 
 12851
World Gate Drive 
 Herndon, Virginia 20170 
 Fax: (703) 234-8315 
 Attention: Nancy Bridgman Lysinger 
  
 and 
  
 Hogan & Hartson L.L.P. 
 875 Third Avenue 
 New York, New York 10022 
 Fax: (212) 918-3100 
 Attention: Christine
M. Pallares, Esq. 
  
 if to the Purchasers to:

  
 c/o Welsh, Carson, Anderson & Stowe 
 320 Park Avenue, Suite 2500 
 New York, New
York 10022 
 Fax: (212) 893-9565 
 Attention: Mr. John D. Clark 
  
 with a
copy to: 
  
 Ropes & Gray LLP 
 45 Rockefeller Plaza 
 New York, New York
10111 
 Fax: (212) 841-5725 
 Attention: Sanford B. Kaynor, Jr., Esq. 
  
 or, in any case, at such
other address or addresses as shall have been furnished in writing by such party to the other parties hereto. All such notices, requests, consents and other communications shall be deemed to have been received (a) in the case of personal delivery,
on the date of such 
  

 21 

 delivery, (b) in the case of mailing, on the fifth business day following the date of such mailing, (c) in the case of
delivery by overnight courier, on the business day following the date of delivery to such courier, and (d) in the case of facsimile, when received. 
  
 Section 8.05. Press Releases and Public Announcements. All public announcements or disclosures relating to this Agreement shall be made only
if mutually agreed upon by the Company and WCAS VIII except to the extent such disclosure is, in the opinion of the Company’s or WCAS VIII’s legal counsel, required by law or by regulation of any applicable national stock exchange or any
SEC recognized trading market or equivalent foreign exchange or trading market; provided that any such required disclosure shall only be made, to the extent consistent with law and regulation of any applicable national stock exchange or SEC
recognized trading market or equivalent foreign exchange or trading market, after consultation with and agreement by WCAS VIII or the Company as applicable. 
  
 Section 8.06. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without
regard to conflict of laws principles. 
  
 Section 8.07.
Entire Agreement. This Agreement (including the Schedules and Exhibits thereto) constitutes the entire agreement of the parties with respect to the subject matter hereof and may not be amended or modified nor any provisions waived except
as set forth in Section 8.10. 
  
 Section 8.08.
Assignment; No Third Party Beneficiaries. This Agreement and the rights, duties and obligations hereunder may not be assigned or delegated by any party hereto without the consent of WCAS VIII. Notwithstanding anything to the contrary
contained herein, (a) the WCAS Purchasers may assign all or any portion of their rights to acquire Notes and Warrants and the related rights and obligations thereunder, subject to the terms of the Subordination Agreement, to any (i) parent,
subsidiary, successor or affiliate and (ii) any third Person without the consent of any other party; and (b) any Constellation Purchaser and any Other Purchaser may assign all or any portion of their rights to acquire Notes and Warrants and the
related rights and obligations thereunder, subject to the terms of the Subordination Agreement, to any parent, subsidiary, successor or affiliate of such Purchaser. It is understood and agreed that, in the event of such assignment, each such
transferee shall, at such time, execute Joinder Agreement (as defined in Section 8.14), and such Purchaser shall not be released from its liabilities under this Agreement. This Agreement is not intended to confer any rights or benefits on any
Persons other than the parties hereto, except as contemplated by this Section 8.08. Any designee or assignee permitted under this Section 8.08 is referred to herein as a “Permitted Designee.” 
  
 Section 8.09. Termination. 
  
 (a) This Agreement may be terminated at any time prior to
the Closing: 
  
 (i) by mutual written agreement of the Company
and WCAS VIII; 
  

 22 

 (ii) by either the Company or WCAS VIII if the Subsequent Closing shall not have been consummated on or
before July 1, 2004, unless extended by mutual agreement or unless the failure to consummate the Subsequent Closing is attributable to a failure on the part of the party seeking to terminate this Agreement to perform any obligation required to be
performed by such party at or prior to the Subsequent Closing Date; or 
  
 (iii) by either the Company or the Purchasers if consummation of the transactions contemplated hereby to be consummated on the Subsequent Closing Date would violate any nonappealable final order, decree or judgment of any court or
Governmental Authority having competent jurisdiction. 
  
 (b) The
party desiring to terminate this Agreement pursuant to Section 8.09(a)(ii) or (iii) hereof shall promptly give notice of such termination to the other party. 
  
 (c) If this Agreement is terminated as permitted by this Section 8.09, such termination shall be without liability of either party (or any stockholder,
director, officer, employee, agent, consultant or representative of such party) to the other parties to this Agreement; provided that if such termination shall result from the willful (i) failure of either party to fulfill a condition to the
performance of the obligations of the other party, (ii) failure of either party to perform a covenant of such party in this Agreement or (iii) breach by either party hereto of any representation or warranty or agreement contained herein, such party
shall be fully liable for any and all losses incurred or suffered by the other party as a result of such failure or breach. The provisions of Sections 8.02, 8.03, 8.04, 8.05, 8.06, and 8.10 shall survive any termination hereof pursuant to this
Section 8.09. 
  
 Section 8.10. Amendments and
Waivers. 
  
 (a) Subject to Section 8.11 hereof, any
provision of this Agreement may be amended or waived if, but only if, such amendment or waiver is in writing and is signed, by the Company and WCAS VIII; provided, however, that each Purchaser shall have the right to consent prior to
any amendment or modification, or waive any provision of this Agreement, if such amendment, modification or waiver adversely affects the Notes purchased by such Purchaser pursuant to this Agreement or such Purchaser’s rights under this
Agreement. 
  
 (b) No failure or delay by any party in exercising
any right, power or privilege hereunder will operate as a waiver thereof, nor will any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege, nor will any waiving of
any right power or privilege operate to waive any other subsequent right, power or privilege. The rights and remedies herein provided will be cumulative and not exclusive of any rights or remedies provided by law. 
  
 Section 8.11. Counterparts. This Agreement may be executed in
two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
  
 Section 8.12. Parties in Interest. All covenants and agreements contained in this Agreement by or on behalf of any party hereto shall bind
and inure to the benefit of the respective successors and Permitted Designees of such party hereto whether so expressed or not. 
  

 23 

 Section 8.13. Taxes. Each party hereto acknowledges that it is responsible for the payment
of its own taxes including filing of corresponding tax returns and submission of any form or other document relating to the imposition of such taxes. Failure to provide any such form or document may result in payments hereunder being made net of an
amount necessary to satisfy applicable withholding tax requirements. 
  
 Section 8.14. Joinder. At any time between the date hereof and the Subsequent Closing, additional third party purchasers may agree to purchase all or any portion of the Notes and Warrants agreed to be purchased for cash by a
WCAS Purchaser on the Initial Closing Date or the Subsequent Closing Date by executing and delivering a joinder agreement in the form attached hereto as Exhibit F hereto (each, a “Joinder Agreement”). Each Joinder Agreement,
if executed pursuant to the foregoing sentence, will constitute an effective assignment pursuant to Section 8.08. Upon execution and delivery of a Joinder Agreement by any such purchaser, such purchaser will be considered an “Other
Purchaser” and a “Purchaser” for purposes of this Agreement and Annex I hereto will be amended to account for such Notes and Warrants to be purchased by such Other Purchaser pursuant to the Joinder Agreement. 
  
 [The remainder of this page intentionally has been left blank.] 
  

 24 

 IN WITNESS WHEREOF, the Company and the Purchaser have executed this Agreement as of the day and year
first above written. 
  

			
	 SAVVIS COMMUNICATIONS CORPORATION

		
	 By:
	 	 /s/ Grier C. Raclin

	 Name:
	 	 Grier C. Raclin

	 Title:
	 	 Chief Legal Officer, Corp. Secretary

  
 Signature
Page to Amended and Restated Securities Purchase Agreement 

			
	 WELSH, CARSON, ANDERSON & STOWE VIII, L.P.

		
	 By
	 	 WCAS VIII Associates LLC,

	 	 	 General Partner

		
	 By:
	 	 /s/ Jonathan M. Rather

	 Jonathan M. Rather

	 Managing Member

  
 Signature
Page to Amended and Restated Securities Purchase Agreement 

			
	 WELSH, CARSON, ANDERSON & STOWE VII, L.P.

		
	 By
	 	 WCAS VII Partners L.P.,

	 	 	 General Partner

		
	 By:
	 	 /s/ Jonathan M. Rather

	 Jonathan M. Rather

	 General Partner

	
	 WELSH, CARSON, ANDERSON & STOWE VI, L.P.

		
	 By
	 	 WCAS VI Partners L.P.,

	 	 	 General Partner

		
	 By:
	 	 /s/ Jonathan M. Rather

	 Jonathan M. Rather

	 General Partner

  
 Signature
Page to Amended and Restated Securities Purchase Agreement 

			
	 WCAS MANAGEMENT CORPORATION

		
	 By:
	 	 /s/ Jonathan M. Rather

	 Jonathan M. Rather

	 Treasurer

	
	 Russell Carson

	 Bruce K. Anderson

	 IRA FBO Bruce K. Anderson

	 Andrew Paul

	 Robert A. Minicucci

	 Anthony J. De Nicola

	 Paul B. Queally

	 D. Scott Mackesy

	 Sanjay Swani

	 IRA FBO James R. Matthews

	 Sean Traynor

	 John Almeida

	 Eric J. Lee

	 IRA FBO Jonathan M. Rather

	 James Hoover

	 Richard Stowe

	 Laura Van Buren

		
	 By:
	 	 /s/ Jonathan M. Rather

	 Jonathan M. Rather

	 Individually and as Attorney-in-Fact

  
 Signature
Page to Amended and Restated Securities Purchase Agreement 

			
	 DANIEL ANDERSON TRUST

		
	 By:
	 	 /s/ Patrick J. Welsh

	 Name: Patrick Welsh

	 Title: Trustee

	
	 KRISTEN ANDERSON TRUST

		
	 By:
	 	 /s/ Patrick J.Welsh

	 Name: Patrick J.Welsh

	 Title: Trustee

	
	 MARK ANDERSON TRUST

		
	 By:
	 	 /s/ Patrick J. Welsh

	 Name: Patrick J. Welsh

	 Title: Trustee

  
 Signature
Page to Amended and Restated Securities Purchase Agreement 

			
	 CONSTELLATION VENTURE CAPITAL II, L.P.

		
	 By:
	 	 Constellation Ventures Management, L.L.C.,

	 	 	 its General Partner

		
	 By:
	 	 The Bear Stearns Companies, Inc.,

	 	 	 its Managing Member

		
	 By:
	 	 /s/ Clifford H. Friedman

	 	 	 Name: Clifford H. Friedman

	 	 	 Title: SMD

	
	 CONSTELLATION VENTURE CAPITAL OFFSHORE II, L.P.

		
	 By:
	 	 Constellation Ventures Management, L.L.C.,

	 	 	 its General Partner

		
	 By:
	 	 The Bear Stearns Companies, Inc.,

	 	 	 its Managing Member

		
	 By:
	 	 /s/ Clifford H. Friedman

	 	 	 Name: Clifford H. Friedman

	 	 	 Title: SMD

	
	 THE BSC EMPLOYEE FUND IV, L.P.

		
	 By:
	 	 Constellation Ventures Management, L.L.C.,

	 	 	 its General Partner

		
	 By:
	 	 The BSCGP, Inc.,

	 	 	 its Managing Member

		
	 By:
	 	 /s/ Clifford H. Friedman

	 	 	 Name: Clifford H. Friedman

	 	 	 Title: SMD

	
	 CVC II PARTNERS, L.L.C.

		
	 By:
	 	 /s/ Clifford H. Friedman

	 	 	 Name: Clifford H. Friedman

	 	 	 Title: SMD

  
 Signature
Page to Amended and Restated Securities Purchase Agreement 

			
	 OAK HILL SPECIAL OPPORTUNITIES FUND, L.P.

		
	 By:
	 	 Oak Hill Special Opportunities GenPar, L.P.,

	 	 	 its General Partner

		
	 By:
	 	 Oak Hill Special Opportunities MGP, LLC,

	 	 	 its General Partner

		
	 By
  
	 	 /s/ William Bohnsack

	 	 	 Name: William Bohnsack

	 	 	 Title: Managing Director

	
	 OAK HILL SPECIAL OPPORTUNITIES FUND (MANAGEMENT), L.P.

		
	 By:
	 	 Oak Hill Special Opportunities GenPar, L.P.,

	 	 	 its General Partner

		
	 By:
	 	 Oak Hill Special Opportunities MGP, LLC,

	 	 	 its General Partner

		
	 By
  
	 	 /s/ William Bohnsack

	 	 	 Name: William Bohnsack

	 	 	 Title: Managing Director

	
	 WFC HOLDINGS CORPORATION

		
	 By
	 	 /s/ Mike Johnson

	 	 	 Name: Mike Johnson

	 	 	 Title: EVP, Attorney in Fact

  
 Signature
Page to Amended and Restated Securities Purchase Agreement 

			
	 OAK HILL SECURITIES FUND, L.P.

		
	 By:
	 	 Oak Hill Securities Gen Par, L.P.

	 	 	 its General Partner

		
	 By:
	 	 Oak Hill Securities MGP, Inc.,

	 	 	 its General Partner

		
	 By:
  
	 	 /s/ William Bohnsack

	 	 	 Name: William Bohnsack

	 	 	 Title: COO

	
	 OAK HILL SECURITIES FUND II, L.P.

		
	 By:
	 	 Oak Hill Securities Gen Par II, L.P.

	 	 	 its General Partner

		
	 By:
	 	 Oak Hill Securities MGP II, Inc.,

	 	 	 its General Partner

		
	 By:
  
	 	 /s/ William Bohnsack

	 	 	 Name: William Bohnsack

	 	 	 Title: COO

	
	 LERNER ENTERPRISES, L.P.

		
	 By:
	 	 Oak Hill Asset Management, Inc.

	 	 	 As advisor and attorney-in-fact to

	 	 	 Lerner Enterprises, L.P.

		
	 By:
  
	 	 /s/ William Bohnsack

	 	 	 Name: William Bohnsack

	 	 	 Title: COO

  
 Signature
Page to Amended and Restated Securities Purchase Agreement 

			
	 P&PK FAMILY LTD. PARTNERSHIP

		
	 By:
	 	 Oak Hill Asset Management, Inc.

	 	 	 As advisor and attorney-in-fact to

	 	 	 P&PK Family Ltd Partnership

		
	 By:
  
	 	 /s/ William Bohnsack

	 	 	 Name: William Bohnsack

	 	 	 Title: COO

	
	 CARDINAL INVESTMENT PARTNERS I, L.P.

		
	 By:
	 	 Oak Hill Asset Management, Inc.

	 	 	 As advisor and attorney-in-fact to

	 	 	 Cardinal Investment Partners I, L.P.

		
	 By:
  
	 	 /s/ William Bohnsack

	 	 	 Name: William Bohnsack

	 	 	 Title: COO

	
	 OAK HILL CREDIT ALPHA FUND, L.P.

		
	 By:
	 	 Oak Hill Credit Alpha Gen Par, L.P.

	 	 	 its General Partner

		
	 By:
	 	 Oak Hill Credit Alpha MGP, Inc.,

	 	 	 its General Partner

		
	 By:
  
	 	 /s/ William Bohnsack

	 	 	 Name: William Bohnsack

	 	 	 Title: COO

	
	 OAK HILL CREDIT ALPHA FUND (OFFSHORE), LTD.

		
	 By:
  
	 	 /s/ William Bohnsack

	 	 	 Name: William Bohnsack

	 	 	 Title: COO

  
 Signature
Page to Amended and Restated Securities Purchase Agreement 

			
	 OAK HILL ADVISORS, L.P.

	 as Investment Manager for

	 The Leland Stanford Junior University

		
	 By:
	 	 Oak Hill Advisors MGP, Inc.

	 	 	 its Managing General Partner

		
	 By:
  
	 	 /s/ William Bohnsack

	 	 	 Name: William Bohnsack

	 	 	 Title: COO

	
	 CARDINAL FUND I, L.P.

		
	 By:
	 	 Cardinal Management I, L.P.,

	 	 	 its General Partner

		
	 By:
	 	 Cardinal MGP, LLC,

	 	 	 its General Partner

		
	 By
	 	 /s/ John H. Fant

	 	 	 Name: John H. Fant

	 	 	 Title: Vice President

	
	 FW SAVVIS INVESTORS, L.P.

		
	 By:
	 	 Group VI 31, L.L.C.,

	 	 	 its General Partner

		
	 By
	 	 /s/ John H. Fant

	 	 	 Name: John H. Fant

	 	 	 Title: Vice President

  
 Signature
Page to Amended and Restated Securities Purchase Agreement 

 ANNEX I 
  
 Part I: Initial Closing 
  

									
	 Purchaser

	  	Aggregate Purchase
Price

	  	Principal Amount
of Notes

	  	Warrant
Shares

	 Welsh, Carson, Anderson & Stowe VIII, L.P.
	  	$	15,000,000	  	$	15,000,000	  	970,588
				
	Part II: Subsequent Closing	  	 	 	  	 	 	  	 
				
	 Purchaser

	  	Aggregate Purchase
Price

	  	Principal Amount
of Notes

	  	Warrant
Shares

	 Welsh, Carson, Anderson & Stowe VIII, L.P.
	  	$	88,783,203	  	$	88,783,203	  	5,744,796
				
	 WCAS Affiliates:
	  	 	 	  	 	 	  	 
				
	 Welsh, Carson, Anderson & Stowe VII, L.P.
	  	$	7,628,108	  	$	7,628,108	  	493,583
				
	 Welsh, Carson, Anderson & Stowe VI, L.P.
	  	 	10,174,944	  	 	10,174,944	  	658,379
				
	 Russell Carson
	  	 	988,655	  	 	988,655	  	63,972
				
	 Bruce K. Anderson
	  	 	1,035,931	  	 	1,035,931	  	67,031
				
	 IRA FBO Bruce K. Anderson
	  	 	180,000	  	 	180,000	  	11,647
				
	 Daniel Anderson Trust
	  	 	11,364	  	 	11,364	  	735
				
	 Kristin Anderson Trust
	  	 	11,364	  	 	11,364	  	735
				
	 Mark Anderson Trust
	  	 	11,364	  	 	11,364	  	735
				
	 Andrew Paul
	  	 	693,195	  	 	693,195	  	44,854
				
	 Robert A. Minicucci
	  	 	340,915	  	 	340,915	  	22,059
				
	 Anthony de Nicola
	  	 	142,048	  	 	142,048	  	9,191
				
	 Paul B. Queally
	  	 	28,410	  	 	28,410	  	1,838
				
	 D. Scott Mackesy
	  	 	11,364	  	 	11,364	  	735
				
	 Sanjay Swani
	  	 	11,364	  	 	11,364	  	735
				
	 IRA FBO James R. Matthews
	  	 	11,364	  	 	11,364	  	735
				
	 Sean Traynor
	  	 	11,364	  	 	11,364	  	735
				
	 John Almeida
	  	 	11,364	  	 	11,364	  	735
				
	 Eric J. Lee
	  	 	5,682	  	 	5,682	  	368
				
	 IRA FBO Jonathan M. Rather
	  	 	11,364	  	 	11,364	  	735
				
	 WCAS Management Corporation
	  	 	2,203,447	  	 	2,203,447	  	142,576
				
	 James Hoover (IRA)
	  	 	73,865	  	 	73,865	  	4,780
				
	 Richard Stowe
	  	 	113,638	  	 	113,638	  	7,353
				
	 Laura Van Buren
	  	 	5,682	  	 	5,682	  	368

									
	 Purchaser

	  	Aggregate Purchase
Price

	  	Principal Amount
of Notes

	  	Warrant
Shares

	 Constellation Purchasers:
	  	 	 	  	 	 	  	 
				
	 Constellation Venture Capital II, L.P.
	  	$	5,287,841	  	$	5,287,841	  	342,154
				
	 Constellation Venture Capital Offshore II, L.P.
	  	 	2,499,930	  	 	2,499,930	  	161,760
				
	 The BSC Employee Fund IV, L.P.
	  	 	2,094,914	  	 	2,094,914	  	135,553
				
	 CVC II Partners, L.L.C.
	  	 	117,315	  	 	117,315	  	7,591
				
	 Oak Hill Purchasers:
	  	 	 	  	 	 	  	 
				
	 Oak Hill Special Opportunities Fund, L.P.
	  	$	8,600,000	  	$	8,600,000	  	556,471
				
	 Oak Hill Special Opportunities Fund (Management), L.P.
	  	 	1,400,000	  	 	1,400,000	  	90,588
				
	 WFC Holding Corporation
	  	 	25,000,000	  	 	25,000,000	  	1,617,647
				
	 Oak Hill Securities Fund, L.P.
	  	 	4,125,000	  	 	4,125,000	  	266,912
				
	 Oak Hill Securities Fund II, L.P.
	  	 	8,250,000	  	 	8,250,000	  	533,824
				
	 Lerner Enterprises, L.P.
	  	 	1,500,000	  	 	1,500,000	  	97,059
				
	 P&PK Family Ltd. Partnership
	  	 	375,000	  	 	375,000	  	24,265
				
	 Cardinal Investment Partners I, L.P.
	  	 	500,000	  	 	500,000	  	32,353
				
	 Oak Hill Credit Alpha Fund, L.P.
	  	 	900,000	  	 	900,000	  	58,235
				
	 Oak Hill Credit Alpha Fund (Offshore), Ltd.
	  	 	1,725,000	  	 	1,725,000	  	111,618
				
	 Oak Hill Advisors, L.P.
	  	 	125,000	  	 	125,000	  	8,088
				
	 Cardinal Fund I, L.P.
	  	 	4,600,000	  	 	4,600,000	  	297,647
				
	 FW Savvis Investors, L.P.
	  	 	5,400,000	  	 	5,400,000	  	349,412

  
 Other Purchasers: 
  
 None.

 ANNEX II 
  
 Oak Hill Participants 
  

	 	1.	Oak Hill Special Opportunities Fund, L.P. 

  

	 	2.	Oak Hill Special Opportunities Fund (Management), L.P. 

  

	 	3.	Oak Hill Securities Fund, L.P. 

  

	 	4.	Oak Hill Securities Fund II, L.P. 

  

	 	5.	Oak Hill Strategic Partners, LP 

  

	 	6.	Oak Hill Capital Partners, LP 

  

	 	7.	Cardinal Fund I, L.P. 

  

	 	8.	FW Savvis Investors, L.P. 

  

	 	9.	WFC Holding Corporation 

  

	 	10.	Lerner Enterprises, L.P. 

  

	 	11.	P&PK Family Ltd. Partnership 

  

	 	12.	Cardinal Investment Partners I, L.P. 

  

	 	13.	Oak Hill Credit Alpha Fund, L.P. 

  
  

	 	14.	Oak Hill Credit Alpha Fund (Offshore), Ltd. 

  

	 	15.	Leland Stanford Junior UniversityEXHIBIT 10.2

 Exhibit 10.2 
  
 EXECUTION VERSION 
  
 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT 
  
 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT, dated as of February 6, 2004, among SAVVIS COMMUNICATIONS CORPORATION, a Delaware corporation
(“Savvis” or the “Company”), WELSH, CARSON, ANDERSON & STOWE VIII, L.P., a Delaware limited partnership (“WCAS”), and the several other entities and persons affiliated with WCAS listed on the
signature pages hereto (the “WCAS Persons” and collectively with WCAS, the “WCAS Investors”), the other investor-parties that hold Warrants (as defined below) that are listed under “Other Investors” on the
signature pages hereto or become a party to this Agreement in accordance with Section 7 (collectively, the “Other Investors”) and any Permitted Transferees (as defined below) that become a party to this Agreement in accordance with
Section 9(d) (together with the Other Investors and the WCAS Investors, the “Investors”). 
  
 W I T N E S S E T H: 
  
 WHEREAS, Savvis Asset Holdings, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Acquisition Subsidiary”) has entered into that certain Asset Purchase Agreement, dated as of
January 23, 2004, as amended by Amendment No. 1 thereto, dated as of January 23, 2004 (the “Acquisition Agreement”), with Cable & Wireless USA, Inc. (“CWUSA”), and Cable & Wireless Internet Services, Inc.
(“CWIS”) and together with CWUSA, CWIS and certain of their subsidiaries, “Sellers”) relating to the sale by Sellers to Acquisition Subsidiary of the Acquired Assets (as defined in the Acquisition Agreement) of
Sellers (the “Acquisition”); 
  
 WHEREAS, in
connection with consummating the Acquisition Subsidiary’s obligations under the Acquisition Agreement, the Company is selling to the WCAS Investors, on the terms and subject to the conditions set forth in the Amended and Restated Securities
Purchase Agreement (the “Securities Purchase Agreement”) among the Company, the WCAS Investors and the other parties that become a party thereto from time to time, Series A Subordinated Notes of the Company in the amount
contemplated by the Securities Purchase Agreement (the “Notes”); 
  
 WHEREAS, as a further inducement to each Investor’s purchase of Notes, the Company is issuing to each Investor warrants (“Warrants”) to purchase shares (the “Warrant Shares”) of
the Company’s Series B Convertible Preferred Stock, $.01 par value per share (“Series B Stock”), which such Series B Stock shall be convertible into shares (the “Conversion Shares”) of the Company’s common
stock, $.01 par value per share (“Common Stock”) upon the satisfaction of certain conditions set forth in the Certificate of Designations of the Series B Stock attached as an exhibit to the Securities Purchase Agreement; 

 
 WHEREAS, as a further inducement to each Investor’s purchase of
Notes, the Company has agreed to grant to each such Investor registration rights with respect to the Conversion Shares; 

 WHEREAS, the parties hereto entered into a Registration Rights Agreement dated January 30, 2004 (the
“Existing Registration Rights Agreement”); and 
  
 WHEREAS, the parties to the Existing Registration Rights Agreement desire to amend and restate the Existing Registration Rights Agreement to make such changes as are necessary to conform with the terms of the Securities Purchase Agreement.

  
 NOW, THEREFORE, the parties hereto agree to amend and restate
the Existing Registration Rights Agreement as follows: 
  
 SECTION
1. Certain Definitions. For purposes of this Agreement, the following terms have the meanings set forth below: 
  
 “Affiliate” means (i) with respect to any WCAS Investor, any other WCAS Investor or any investment limited partnership
affiliated therewith, any general partner or principal of WCAS, any such other WCAS Investor or any such investment limited partnership and (ii) with respect to any Other Investor, any investment limited partnership affiliated therewith, any general
partner or principal of such Other Investor or any investment limited partnership. 
  
 “Commission” means the Securities and Exchange Commission or any other federal agency at the time administering the
Securities Act. 
  
 “Covered Warrant
Common Shares” means the shares of Common Stock into which the Series B Stock is convertible and any other shares of Common Stock distributable on, with respect to, or in substitution of such shares. 
  
 “Exchange Act” means the Securities
Exchange Act of 1934 or any successor federal statute, and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time. 
  
 “Permitted Transferee” has the meaning ascribed to such term in Section 9(d).

  
 “Person” means any
individual, corporation, partnership, limited liability company, joint venture, association, joint-stock issuer, interest, trust or unincorporated organization (including any subdivision or ongoing business of any such entity or substantially all of
the assets of any such entity, subdivision or business). 
  
 “Restricted Stock” means, at any time, the Covered Warrant Common Shares and any shares of Common Stock issuable upon or issuable with respect to the Covered Warrant Common Shares by way of stock
dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation or other reorganization or otherwise, in each case only so long as such shares have not been sold to the public pursuant to an effective
registration statement under, or pursuant to Rule 144 under, the Securities Act. 
  

 2 

 “Savvis Stock” means any shares of capital stock of Savvis. 

 
 “Securities Act” means the Securities
Act of 1933 (or any successor federal statute) and the rules and regulations of the Commission thereunder, as the same shall be in effect at the time. 
  
 “Transfer” means, with respect to any Savvis Stock, the sale, transfer, assignment, pledge, encumbrance, distribution or
other disposition of such securities. 
  
 SECTION 2. Shares;
Restrictions on Transfer; Legends. 
  
 (a) Each Investor
agrees that it will not effect any Transfer of any Warrants, any shares of Series B Stock or any shares of Restricted Stock unless such Transfer is made pursuant to an effective registration statement under the Securities Act or pursuant to an
exemption from, or in a transaction not subject to, the registration requirements of the Securities Act (and, in either case, in compliance with all applicable state securities laws). 
  
 (b) Savvis agrees, and each Investor understands and consents, that Savvis will not cause or permit the Transfer of any
Warrants, any shares of Series B Stock or any shares of Restricted Stock to be made on its books (or on any register of securities maintained on its behalf) unless the Transfer is permitted by, and has been made in accordance with, (x) the terms of
this Agreement and (y) all applicable federal and state securities laws. Each Investor agrees that in connection with any Transfer of Warrants, shares of Series B Stock or Restricted Stock that is not made pursuant to a registered public offering,
Savvis may request an opinion of legal counsel reasonably acceptable to Savvis (it being agreed that Ropes & Gray LLP shall be satisfactory) for the transferring Investor stating that such transaction is exempt from registration under all
applicable laws; provided, however, that no such opinion shall be required in the case of a Transfer by any Investor to its Affiliates or, if any such entity is a partnership or limited liability company, a transfer by any Investor or
its affiliates to its partners or members. Any Transfer of Warrants, shares of Series B Stock or Restricted Stock other than in accordance with this Section will be void. 
  
 (c) From and after the date hereof (and until such time as such securities have been sold to the public pursuant to an
effective registration statement under the Securities Act or pursuant to Rule 144 or the holder of such securities shall have requested the issuance of new certificates in writing and delivered to Savvis an opinion of legal counsel reasonably
acceptable to Savvis (it being agreed that Ropes & Gray LLP shall be satisfactory) to such effect) all certificates representing Warrants, shares of Series B Stock or shares of Restricted Stock that are held by any Investor shall bear legends
which shall state the following: 
  
 “THE
SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, NOR ANY APPLICABLE STATE LAW, AND NO INTEREST HEREIN MAY BE OFFERED, SOLD, ASSIGNED, DISTRIBUTED, PLEDGED OR OTHERWISE TRANSFERRED UNLESS
(A) THERE IS AN EFFECTIVE REGISTRATION STATEMENT WITH RESPECT THERETO UNDER SAID ACT AND LAWS OR (B) SUCH TRANSACTION IS EXEMPT FROM SUCH REGISTRATION. 
  

 3 

 THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE TERMS AND CONDITIONS OF
A REGISTRATION RIGHTS AGREEMENT AMONG THE ISSUER AND THE OTHER PARTIES THERETO. COPIES OF SUCH AGREEMENT MAY BE OBTAINTED AT NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE ISSUER.” 
  
 SECTION 3. Registration Rights. 
  
 (a) Demand Registration Rights. If Savvis shall, at any time, be
requested by WCAS (or its Permitted Transferees) in a writing that states the number of shares of Restricted Stock to be sold and the intended method of disposition thereof (each such written request, a “Demand Notice”), to effect a
registration under the Securities Act of all or any portion of the Restricted Stock issued or issuable upon the conversion of the Series B Stock then held by such person, Savvis shall immediately notify in writing (each such notice, a
“Demand Further Notice”) each other Investor (other than the requesting Investor) of such proposed registration and shall use its reasonable best efforts to register under the Securities Act (each such registration, a
“Demand Registration”), for public sale in accordance with the method of disposition specified in such Demand Notice, the number of shares of Restricted Stock specified in such Demand Notice (plus the number of shares of Restricted
Stock specified in any written requests for registration of shares of Restricted Stock that are received from other Investors (other than the requesting Investors) within 30 days after receipt by such other Investors of a Demand Further Notice).
Notwithstanding anything to the contrary contained herein, Savvis shall not be obligated pursuant to this paragraph (a) to file and cause to become effective (i) more than two Demand Registrations in the aggregate requested by WCAS or its Permitted
Transferees or (ii) any Demand Registration with a proposed aggregate offering price of less than $25.0 million. 
  
 (b) Additional Short-Form Registration Rights. If Savvis becomes eligible to use Form S-3 or a successor form, Savvis shall use its reasonable best
efforts to continue to qualify at all times for registration on Form S-3 or such successor form. If (x) Savvis is eligible to register shares of Common Stock on Form S-3 or a successor form and (y) it is requested by WCAS in a writing that states
the number of shares of Restricted Stock to be sold and the intended method of disposition thereof (each such written request, a “Short Form Registration Notice”), to effect a registration on Form S-3 or such successor form (a
“Short Form Registration”) of all or any portion of the Restricted Stock then held by WCAS, Savvis shall immediately notify in writing (each such notice, a “Short Form Further Notice”) each Investor of such proposed
registration and shall use its reasonable best efforts to register on Form S-3 or such successor form, for public sale in accordance with the method of disposition specified in such Short Form Registration Notice, the number of shares of Restricted
Stock specified in such Short Form Registration Notice (plus the number of shares of Restricted Stock specified in any written requests for registration of shares of Restricted Stock that are received from other Investors (other than the requesting
Investors) within 30 days after receipt by such other Investors of a Short Form Further Notice); provided, WCAS shall not have the right to request a Short Form Registration unless the proposed aggregate offering price (which shall be
specified in the Short Form Registration Notice delivered in connection therewith) is at least $10.0 million. 
  

 4 

 (c) Certain Provisions Relating to Required Registrations. Notwithstanding anything to the
contrary contained in this Agreement, Savvis shall not be obligated to effect any registration under paragraph (a) or (b) above except in accordance with the following provisions: 
  
 (i) the obligations of Savvis under paragraph (a) or (b) above, as the case may be, to effect a registration
shall be deemed satisfied only when a registration statement covering all of the shares of Restricted Stock specified in the applicable Demand Notice or Short Form Registration Notice, as the case may be, for sale in accordance with the intended
method of disposition specified by the requesting Investors, shall have become effective and, if such method of disposition is a firm commitment underwritten public offering, all such shares of Restricted Stock shall have been sold pursuant thereto;

  
 (ii) so long as Savvis has provided written
notice of a prior registration statement to each Investor in compliance with paragraph (d) below, Savvis shall not be obligated under paragraph (a) or (b) above to file and cause to become effective any registration statement so long as such written
notice was received by Investors prior to the delivery of the applicable Demand Notice or Short Form Registration Notice, as the case may be (and such prior registration statement has not been withdrawn); provided, Savvis shall not be
permitted to delay a requested registration under paragraph (a) or (b) above in reliance on this paragraph (c)(ii) more than 180 days following the effective date of such prior registration statement; 
  
 (iii) if the proposed method of disposition specified by the
requesting Investors shall be an underwritten public offering, the number of shares of Restricted Stock to be included in such an offering may be reduced (pro rata among the Investors seeking to include Restricted Stock in such offering based on the
number of shares of Restricted Stock so requested to be registered by such Investors, it being understood that there will be no such reduction of shares of Restricted Stock owned by Investors unless and until such reduction is first applied against
shares of Common Stock held by stockholders of the Company who are not Investors and who, through other contractual rights with the Company, determine to participate in any such Demand Registration or Short Form Registration, and then applied to any
shares of Common Stock to be sold by the Company for its own account) if and to the extent that, in the good faith opinion of the managing underwriter of such offering, inclusion of all shares would adversely affect the marketing (including, without
limitation, the offering price) of the Restricted Stock to be sold; 
  
 (iv) in the event that the proposed method of disposition specified by the requesting Investors shall be an underwritten public offering, the requesting Investors holding a majority of the Restricted Stock included in
such offering shall choose the managing underwriter (which shall be a nationally recognized investment banking firm reasonably acceptable to the Company); 
  
 (v) Savvis shall be entitled to include in any registration referred to in paragraph (a) or (b) above, as the case may be, for sale in
accordance with the method of disposition specified by the requesting Investors, shares of Common Stock to be sold by Savvis for its own account, except as and to the extent that, in the opinion of the 
  

 5 

 managing underwriter of such offering (if such method of disposition shall be an underwritten public
offering), such inclusion would adversely affect the marketing (including, without limitation, the offering price) of the Restricted Stock to be sold; 
  
 (vi) except as provided in paragraph (c)(v) above, Savvis will not effect any other registration of Common Stock, whether for its own
account or that of other holder(s) of Common Stock of Savvis, from the date of receipt of a Demand Notice or the date of receipt of a Short Form Registration Notice, as the case may be, for an underwritten public offering until the completion of the
period of distribution of the registration contemplated thereby (determined as hereinafter provided); 
  
 (vii) if any Investor (other than the requesting Investor) requests that some or all of such Investor’s shares of Restricted Stock be
included in an offering initiated pursuant to paragraph (a) or (b) above, and the registration is to be, in whole or in part, an underwritten public offering of Common Stock, such request by such Investor shall specify that such Investor’s
Restricted Stock is to be included in the underwriting on the same terms and conditions as the shares of Restricted Stock otherwise being sold through the underwriter; and 
  
 (viii) if, while a registration is pending, Savvis determines in good faith that the filing of a
registration statement would require the disclosure of a material transaction or another set of material facts and such disclosure would either have a material adverse effect on such material transaction or Savvis and its subsidiaries (taken as a
whole), then Savvis shall not be required to effect a registration pursuant to paragraph (a) or (b) above, as the case may be, until the earlier of (A) the date upon which such material information is otherwise disclosed to the public or ceases to
be material and (B) 90 days after Savvis makes such good faith determination; provided, Savvis shall not be permitted to delay a requested registration under paragraph (a) or (b) above in reliance on this paragraph (c)(viii) more than twice or for
more than an aggregate of 90 days in any consecutive twelve-month period. 
  
 (d) Piggyback Registration Rights. If at any time Savvis proposes to register any of its Common Stock under the Securities Act for sale to the public, whether for its own account or for the account of other
security holders or both (other than a registration on Form S-4 or Form S-8 promulgated under the Securities Act (or any successor forms thereto) or any other form not available for registering the Restricted Stock for sale to the public), it will
give written notice (each such notice a “Piggyback Notice”) at such time to each Investor of its intention to do so. Upon the written request of any Investor, given within 30 days after receipt by such holder of the Piggyback
Notice, to register any of its Restricted Stock (which request shall state the amount of Restricted Stock to be so registered and the intended method of disposition thereof), Savvis will use its reasonable best efforts to cause the Restricted Stock,
as to which registration shall have been so requested, to be included in the securities to be covered by the registration statement proposed to be filed by Savvis, all to the extent requisite to permit the sale or other disposition by such Investor
(in accordance with its written request) of such Restricted Stock so registered; provided, nothing herein shall prevent Savvis from abandoning or delaying such registration at any time. In the event that any registration referred to in this
paragraph (d) shall be, in whole or in part, an underwritten public offering of Common Stock of Savvis, any 
  

 6 

 request by an Investor pursuant to this paragraph (d) to register Restricted Stock shall specify either that (i) such
Restricted Stock is to be included in the underwriting on the same terms and conditions as the shares of Savvis Common Stock otherwise being sold through underwriters under such registration or (ii) such Restricted Stock is to be sold in the open
market without any underwriting, on terms and conditions comparable to those normally applicable to offerings of Common Stock in reasonably similar circumstances. The number of shares of Restricted Stock to be included in such an underwritten
offering may be reduced (x) if the stockholder or stockholders of Savvis requesting to have shares of Restricted Stock included in a registration contemplated by this Section 3(d) are Investors, pro rata among the requesting Investors based upon the
number of shares of Restricted Stock so requested to be registered or (y) if stockholders of Savvis other than Investors also request to have their shares of Common Stock included in a registration contemplated by this Section 3(d), pro rata among
all the requesting stockholders based upon the number of shares of Common Stock of Savvis so requested to be registered, if and to the extent that the managing underwriter of such offering shall be of the good faith opinion that such inclusion would
adversely affect the marketing (including, without limitation, the offering price) of the securities to be sold by Savvis therein, or by the other security holders for whose benefit the registration statements has been filed. 
  
 (e) Holdback Agreement. Notwithstanding anything to the contrary
contained in this Agreement, (i) if there is a firm commitment underwritten public offering of securities of Savvis pursuant to a registration covering Restricted Stock and an Investor does not elect to sell his Restricted Stock to the underwriters
of Savvis’s securities in connection with such offering, such Investor shall refrain from selling such Restricted Stock during the period of distribution (determined as hereinafter provided) of Savvis’s securities by such underwriters and
the period in which the underwriting syndicate participates in the after market; provided, such Investor shall, in any event, be entitled to sell its Restricted Stock commencing on the 180th day after the effective date of such registration
statement; and (ii) if there is a firm commitment underwritten public offering of securities of Savvis by Savvis, each Investor agrees that, except to the extent otherwise permitted to participate in such offering pursuant to paragraph (d) above,
upon the request of the managing underwriter in such offering, such Investor shall not sell Savvis Common Stock held by such Investor for a period of 180 days from the effective date of the registration statement relating thereto and such Investor
shall execute a lockup agreement in the form customarily used in such transactions; provided, further, however, that Investors that are investment limited partnerships may make a distribution in kind of their shares of Restricted Stock to their
limited partners or members during such period of distribution so long as such limited partners or members agree to be bound by the terms of this Section 3(e). 
  

(f) Certain Registration Procedures. If and whenever Savvis is required by the provisions of this Section 3 to use its reasonable best efforts
to effect the registration of Restricted Stock under the Securities Act, Savvis will, as expeditiously as possible: 
  
 (i) prepare (and afford counsel for the selling Investors reasonable opportunity to review and comment thereon) and file with the
Commission a registration statement with respect to such securities and use its reasonable best efforts to cause such registration statement to become and remain effective for the period of the distribution contemplated thereby (determined as
hereinafter provided); 
  

 7 

 (ii) prepare (and afford counsel for the selling Investors reasonable opportunity to
review and comment thereon) and file with the Commission such amendments and supplements to such registration statement and the prospectus used in connection therewith as may be necessary to keep such registration statement effective for the period
of distribution contemplated thereby (determined as hereinafter provided) and to comply with the provisions of the Securities Act with respect to the disposition of all Restricted Stock covered by such registration statement in accordance with the
selling Investors’ intended method of disposition set forth in such registration statement for such period; 
  
 (iii) furnish to each selling Investor and to each underwriter such number of copies of the registration statement and the prospectus
included therein (including, without limitation, each preliminary prospectus) as such persons may reasonably request in order to facilitate the public sale or other disposition of the Restricted Stock covered by such registration statement;

  
 (iv) use its reasonable best efforts to
register or qualify the Restricted Stock covered by such registration statement under the securities or blue sky laws of such jurisdictions as the sellers of Restricted Stock or, in the case of an underwritten public offering, the managing
underwriter, shall reasonably request; provided, Savvis will not be required to (x) qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify but for this paragraph (iv), (y) subject itself to taxation
in any such jurisdiction or (z) consent to general service of process in any jurisdiction; 
  
 (v) immediately notify each selling Investor under such registration statement and each underwriter, at any time when a prospectus
relating thereto is required to be delivered under the Securities Act, of the happening of any event as a result of which the prospectus contained in such registration statement, as then in effect, includes an untrue statement of a material fact or
omits to state any material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing, and each Investor agrees to refrain from further using such prospectus upon
receipt of such notice; 
  
 (vi) use its
reasonable best efforts (if the offering is underwritten) to furnish, at the request of any selling Investor, on the date that Restricted Stock is delivered to the underwriters for sale pursuant to such registration: (A) an opinion dated such date
of counsel representing Savvis for the purposes of such registration, addressed to the underwriters and to such selling Investor, stating that such registration statement has become effective under the Securities Act and that (1) to the best
knowledge of such counsel, no stop order suspending the effectiveness thereof has been issued and no proceedings for that purpose have been instituted or are pending or contemplated under the Securities Act, (2) the registration statement, the
related prospectus, and each amendment or supplement thereof, comply as to form in all material respects with the requirements of the Securities Act and the applicable rules and regulations of the Commission thereunder (except that such counsel need
express no opinion as to financial statements, the notes thereto, and the financial schedules and other financial and statistical data contained therein) and (3) to such other effects as may reasonably be 
  

 8 

 requested by counsel for the underwriters, and (B) a letter dated such date from the independent public
accountants retained by Savvis, addressed to the underwriters, stating that they are independent public accountants within the meaning of the Securities Act and that, in the opinion of such accountants, the financial statements of Savvis included in
the registration statement or the prospectus, or any amendment or supplement thereof, comply as to form in all material respects with the applicable accounting requirements of the Securities Act, and such letter shall additionally cover such other
financial matters (including, without limitation, information as to the period ending no more than five business days prior to the date of such letter) with respect to the registration in respect of which such letter is being given as such
underwriters may reasonably request; and 
  
 (vii) make available for inspection by any selling Investor, any underwriter participating in any distribution pursuant to such registration statement, and any attorney, accountant or other agent retained by such selling Investor or its
Permitted Transferee or underwriter, all financial and other records, pertinent corporate documents and properties of Savvis, and cause Savvis’s officers, directors and employees to supply all information reasonably requested by any such
selling Investor or its Permitted Transferee, underwriter, attorney, accountant or agent in connection with such registration statement and permit such selling Investor, attorney, accountant or agent to participate in the preparation of such
registration statement. 
  
 For purposes of paragraphs (f)(i) and (f)(ii) above
(as well as paragraphs (c)(vi) and (e) above), the “period of distribution” of Restricted Stock in a firm commitment underwritten public offering shall be deemed to extend until each underwriter has completed the distribution of all
securities purchased by it, and the period of distribution of Restricted Stock in any other registration shall be deemed to extend until the sale of all Restricted Stock covered thereby, but in either case, such period shall not extend beyond the
180th day (or, in the case of paragraph (c)(vi) above, the 90th day) after the effective date of the registration statement filed in connection therewith. 
  
 (g) Information From Selling Investors. In connection with each registration hereunder, Investors selling Restricted Stock will furnish to Savvis
in writing such information with respect to themselves and the proposed distribution by them as shall be reasonably necessary in order to assure compliance with federal and applicable state securities laws. 
  
 (h) Underwriting Agreement. In connection with any registration
pursuant to this Section 3 that covers an underwritten public offering, Savvis and Investors selling Restricted Stock each agree to enter into a written agreement with the managing underwriter selected in the manner herein provided in such form and
containing such provisions as are customary in the securities business for such an arrangement between underwriters, selling stockholders and companies of Savvis’ size and investment stature; provided, (i) such agreement shall not contain any
such provision applicable to Savvis which is inconsistent with the provisions hereof and (ii) the time and place of the closing under said agreement shall be as mutually agreed upon among Savvis, such managing underwriter and, except in the case of
a registration pursuant to paragraph (d) above, WCAS, if participating in such offering. 
  

 9 

 (i) Expenses. Savvis will pay all Registration Expenses incurred by it in complying with Section 3
of this Agreement. All Selling Expenses incurred in connection with any registered offering of securities pursuant to this Section 3, including Restricted Stock, shall be borne by the participating sellers in proportion to the number of shares sold
by each, or by such persons other than Savvis (except to the extent Savvis shall be a seller) as they may agree. All expenses incident to performance of or compliance by Savvis with Section 3 hereof, including, without limitation, all Commission,
stock exchange or National Association of Securities Dealers, Inc. (“NASD”) registration and filing fees (including, without limitation, fees and expenses incurred in connection with the listing of the Common Stock of Savvis on any
securities exchange or exchanges), printing, distribution and related expenses, fees and disbursements of counsel and independent public accountants for Savvis and the reasonable fees and expenses of one counsel for all selling securityholders, all
fees and expenses incurred in connection with compliance with state securities or blue sky laws and the rules of the NASD or any securities exchange, transfer taxes and fees of transfer agents and registrars, but excluding any Selling Expenses, are
herein called “Registration Expenses”. All underwriting discounts and selling commissions applicable to the sale of Restricted Stock are herein called “Selling Expenses”. 
  
 SECTION 4. Indemnification Rights and Obligations In Respect of Registered
Offerings of Restricted Stock. 
  
 (a) Savvis
Indemnification of Selling Investors. In the event of a registration of any of the Restricted Stock under the Securities Act pursuant to Section 3 of this Agreement, Savvis will indemnify and hold harmless each seller of Restricted Stock
thereunder and each other person, if any, who controls such seller within the meaning of the Securities Act, against any losses, claims, damages or liabilities, joint or several, (or actions in respect thereof) to which such seller or controlling
person may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of any material
fact contained in any registration statement under which such Restricted Stock was registered under the Securities Act, any preliminary prospectus or final prospectus contained therein, or any amendment or supplement thereof, or arise out of or are
based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse each such seller and each such controlling person for any legal
or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action; provided, Savvis will not be liable in any such case if and to the extent that any such loss,
claim, damage, liability or action arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission so made in conformity with information furnished by such seller or such controlling person in writing
specifically for use in such registration statement or prospectus. 
  
 (b) Selling Investor Indemnification of Savvis and the Other Selling Stockholders. In the event of a registration of any of the Restricted Stock under the Securities Act pursuant to Section 3 of this Agreement, each seller of such
Restricted Stock thereunder, severally and not jointly, will indemnify and hold harmless Savvis and each person, if any, who controls Savvis within the meaning of the Securities Act, each officer of Savvis who signs the registration statement, each
director of Savvis, each underwriter and each person who controls any 
  

 10 

 underwriter within the meaning of the Securities Act, and each other seller of Restricted Stock and each person who
controls any such other seller of Restricted Stock, against all losses, claims, damages or liabilities, joint or several, (or actions in respect thereof) to which Savvis or such officer or director or underwriter or other seller or controlling
person may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of any material
fact contained in the registration statement under which such Restricted Stock was registered under the Securities Act, any preliminary prospectus or final prospectus contained therein, or any amendment or supplement thereof, or arise out of or are
based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse Savvis and each such officer, director, underwriter, other
seller of Restricted Stock and controlling person for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action; provided, such seller will be
liable hereunder in any such case if and only to the extent that any such loss, claim, damage, liability or action arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in reliance upon
and in conformity with information pertaining to such seller, as such, furnished in writing to Savvis by such seller specifically for use in such registration statement or prospectus; provided, further, the liability of each seller
hereunder shall be limited to the proportion of any such loss, claim, damage, liability or expense which is equal to the proportion that the public offering price of shares sold by such seller under such registration statement bears to the total
public offering price of all securities sold thereunder, but not to exceed the proceeds (net of underwriting discounts and commissions) received by such seller from the sale of Restricted Stock covered by such registration statement. 
  
 (c) Indemnification Procedures. Promptly after receipt by an
indemnified party hereunder of notice of the commencement of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party hereunder, notify the indemnifying party in writing thereof, but the
omission so to notify the indemnifying party shall not relieve it from any liability which it may have to any indemnified party other than under this Section 4. In case any such action shall be brought against any indemnified party and it shall
notify the indemnifying party of the commencement thereof, the indemnifying party shall be entitled to participate in and, to the extent it shall wish, to assume and undertake the defense thereof with counsel satisfactory to such indemnified party,
and, after notice from the indemnifying party to such indemnified party of its election so to assume and undertake the defense thereof, the indemnifying party shall not be liable to such indemnified party under this Section 4 for any legal expenses
subsequently incurred by such indemnified party in connection with the defense thereof other than reasonable costs of investigation and of liaison with counsel so selected; provided, if the defendants in any such action include both the
indemnified party and the indemnifying party and the indemnified party shall have reasonably concluded that there may be reasonable defenses available to it which are different from or additional to those available to the indemnifying party, or if
the interests of the indemnified party reasonably may be deemed to conflict with the interests of the indemnifying party, the indemnified party shall have the right to select a separate counsel and to assume such legal defenses and otherwise to
participate in the defense of such action, with the expenses and fees of such separate counsel and other expenses related to such participation to be reimbursed by the indemnifying party as incurred. Notwithstanding the foregoing, any indemnified
party shall have the right to retain its own 
  

 11 

 counsel in any such action, but the fees and disbursements of such counsel shall be at the expense of such indemnified
party unless (i) the indemnifying party shall have failed to retain counsel for the indemnified person as aforesaid or (ii) the indemnifying party and such indemnified party shall have mutually agreed to the retention of such counsel. It is
understood that the indemnifying party shall not, in connection with any action or related actions in the same jurisdiction, be liable for the fees and disbursements of more than one separate firm qualified in such jurisdiction to act as counsel for
the indemnified party. The indemnifying party shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party
agrees to indemnify the indemnified party from and against any loss or liability by reason of such settlement or judgment. The indemnification of underwriters provided for in this Section 4 shall be on such other terms and conditions as are at the
time customary and reasonably required by such underwriters. In that event the indemnification of the sellers of Restricted Stock in such underwriting shall at the sellers’ request be modified to conform to such terms and conditions.

  
 (d) Contribution. If the indemnification provided for
in paragraphs (a) and (b) of this Section 4 is unavailable or insufficient to hold harmless an indemnified party under such paragraphs in respect of any losses, claims, damages or liabilities or actions in respect thereof referred to therein, then
each indemnifying party shall in lieu of indemnifying such indemnified party contribute to the amount paid or payable by such indemnified party as a result of such losses, claims, damages, liabilities or actions in such proportion as appropriate to
reflect the relative fault of Savvis, on the one hand, and the underwriters and the sellers of such Restricted Stock, on the other, in connection with the statements or omissions which resulted in such losses, claims, damages, liabilities or actions
as well as any other relevant equitable considerations, including, without limitation, the failure to give any notice under paragraph (c) above. The relative fault shall be determined by reference to, among other things, whether the untrue or
alleged untrue statement of a material fact relates to information supplied by Savvis, on the one hand, or the underwriters and the sellers of such Restricted Stock, on the other, and to the parties’ relative intent, knowledge, access to
information and opportunity to correct or prevent such statement or omission. Savvis and each of the Investors agree that it would not be just and equitable if contributions pursuant to this paragraph were determined by pro rata allocation (even if
all of the sellers of such Restricted Stock were treated as one entity for such purpose) or by any other method of allocation which did not take account of the equitable considerations referred to above in this paragraph. The amount paid or payable
by an indemnified party as a result of the losses, claims, damages, liabilities or action in respect thereof, referred to above in this paragraph, shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party
in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this paragraph, the sellers of such Restricted Stock shall not be required to contribute any amount in excess of the amount, if any, by which
the total price at which the Restricted Stock sold by each of them was offered to the public exceeds the amount of any damages which they would have otherwise been required to pay by reason of such untrue or alleged untrue statement or omission. No
person guilty of fraudulent misrepresentations (within the meaning of Section 11(f) of the Securities Act), shall be entitled to contribution from any person who is not guilty of such fraudulent misrepresentation. 
  
 SECTION 5. Rule 144. Savvis has filed and agrees with the Investors
that from and after the date hereof it shall continue to file any and all reports required to be filed by it 
  

 12 

 under the Securities Act and the Exchange Act and the rules and regulations adopted by the Commission thereunder, or, if
Savvis is not required to file any such reports, it shall, upon the written request of any Investor, make publicly available such information as is necessary to permit sales pursuant to Rule 144 under the Securities Act. Upon the written request of
any Investor, Savvis shall promptly furnish to such Investor a written statement by Savvis as to its compliance with the reporting requirements set forth in this Section 5. 
  
 SECTION 6. Duration of Agreement. Unless otherwise set forth in this Agreement, the provisions of this Agreement
shall survive so long as any Investor owns Warrant Shares or Restricted Stock. 
  
 SECTION 7. Joinder. The Investors and the Company agree that any Person who becomes a party to the Securities Purchase Agreement in accordance with Section 8.14 thereof will automatically become a party to this
Agreement and for all purposes be considered an “Other Investor” hereunder. 
  
 SECTION 8. Representations and Warranties. Each party hereto, severally and not jointly, represents and warrants to the other parties hereto as follows: 
  
 (i) such party has the corporate or partnership power and
authority, as the case may be, to execute and deliver this Agreement and to perform its obligations hereunder. The execution, delivery and performance by such party of this Agreement have been duly authorized by all requisite corporate or
partnership action, as the case may be, on the part of such party and will not (i) violate any provision of law, any order of any court or other agency of government, the charter and other organizational documents of such party, or any provision of
any indenture, agreement or other instrument by which such party or any of such party’s properties or assets is bound; (ii) conflict with, result in a breach of or constitute (with due notice or lapse of time or both) a default under any such
indenture, agreement or other instrument; or (iii) result in the creation or imposition of any lien, charge or encumbrance of any nature upon any of the properties or assets of such party; and 
  
 (ii) this Agreement has been duly executed and delivered by
such party and constitutes a legal, valid and binding agreement of such party, enforceable against such party in accordance with its terms, subject, as to enforcement of remedies, to applicable bankruptcy, insolvency, reorganization, moratorium and
similar laws from time to time in effect affecting the enforcement of creditors’ rights generally and to general principles of equity. 
  
 SECTION 9. Miscellaneous. 
  
 (a) Additional Registration Rights. Without the prior written consent of the Investors, Savvis shall not grant any registration rights to any other
person that are inconsistent or conflict with the registration rights granted hereunder, including, without limitation, rights to participate in a Demand Registration which could result in reduction (on a pro rata or other basis) in the number of
shares of Common Stock held by such Investor or its Permitted Transferees, as applicable, to be included in any underwritten offering made in respect of such Demand Registration. 
  

 13 

 (b) Headings. Headings of sections and paragraphs of this Agreement are inserted for convenience
of reference only and shall not affect the interpretation or be deemed to constitute a part hereof. 
  
 (c) Severability. In the event that any one or more of the provisions contained in this Agreement or in any other instrument referred to herein
shall, for any reason, be held to be invalid, illegal or unenforceable, such invalidity, illegality or unenforceability shall not affect any other provisions of this Agreement. 
  
 (d) Benefits of Agreement. All covenants and agreements contained herein by or on behalf of any of the parties hereto
shall bind and inure solely and exclusively to the benefit of the respective successors and permitted assigns of the parties hereto. Except as expressly permitted hereby, each party’s rights and obligations under this Agreement shall not be
subject to assignment or delegation by any party hereto, and any attempted assignment or delegation in violation hereof shall be null and void. Notwithstanding anything to the contrary contained in this Agreement, each Investor will be entitled to
assign all or any portion of its rights and obligations under this Agreement to a transferee of Warrants, Series B Stock and Conversion Shares (to the extent permitted or not prohibited by Section 2) held by such Investor (each such transferee, a
“Permitted Transferee”) which Permitted Transferee shall be treated as a party to this Agreement with the same rights and obligations as such transferring Investor; provided, however, that any such Permitted Transferee
shall agree to be bound by this Agreement. 
  
 (e) Entire
Agreement; Termination of Existing Agreements. This Agreement and the Securities Purchase Agreement constitute the entire agreement of the parties with respect to the subject matter hereof. 
  
 (f) Modification. This Agreement may not be modified or amended except
by a writing signed by Savvis and WCAS; provided that this Agreement may not be so amended in any manner that adversely affects the rights or obligations of any Investor unless the consent of such Investor is obtained in writing prior to the
effectiveness of such amendment. Any waiver of any provision of this Agreement must be in a writing signed by the party against whom enforcement of such waiver is sought. 
  
 (g) Notices. Any notice or other communications required or permitted hereunder shall be deemed to be sufficient if
contained in a written instrument delivered in person or duly sent by national overnight courier service, by first class certified mail, postage prepaid, or by facsimile (followed by delivery by overnight courier) addressed to such party at the
address or facsimile number set forth on the signature pages hereto or, in any case, at such other address or facsimile number as shall have been furnished in writing by such party to the other parties hereto. All such notices, requests, consents
and other communications shall be deemed to have been received (1) in the case of personal or courier delivery, on the date of such delivery, (2) in the case of mailing, on the fifth business day following the date of such mailing and (3) in the
case of facsimile, when received. 
  

 14 

 (h) Counterparts. This Agreement may be executed in any number of counterparts, and each such
counterpart hereof shall be deemed to be an original instrument, but all such counterparts together shall constitute but one agreement. 
  
 (i) Changes in Common Stock of Savvis. If, and as often as, there are any changes in the Common Stock of Savvis by way of stock split, stock
dividend, combination or reclassification, or through merger, consolidation, reorganization or recapitalization, or by any other means, appropriate adjustment shall be made in the provisions hereof as may be required so that the rights and
privileges granted hereby shall continue with respect to the Restricted Stock as so changed. 
  
 (j) Specific Performance. Each party hereto agrees that a remedy at law for any breach or threatened breach by such party of this Agreement would be inadequate and therefore agrees that any other party hereto
shall be entitled to specific performance of this Agreement in addition to any other available rights and remedies in case of any such breach or threatened breach. 
  
 (k) Binding Effect. Anything herein to the contrary notwithstanding, it is hereby expressly agreed and understood by
each of the parties hereto that this Agreement shall be a binding obligation of the Company with regard to each Investor executing this Agreement, and a binding obligation of each Investor executing this Agreement with regard to the Company, in each
case in accordance to with the terms hereof. The failure or refusal of any Investor to execute this Agreement shall in no way negate, relieve, invalidate or otherwise affect the rights and obligations of the Company and each Investor executing this
Agreement as set forth herein. 
  
 (l) Governing
Law. This agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to the conflicts of laws provisions thereof. 
  
 * * * * * 
  

 15 

 IN WITNESS WHEREOF, each of the parties hereto has duly executed and delivered this Agreement as of the
day and year first above written. 
  

			
	 SAVVIS:
  
 SAVVIS COMMUNICATIONS CORPORATION
 a Delaware Corporation

	
	 By /s/ Grier C. Raclin

	 Name: Grier C. Raclin

	 Title: Chief Legal Officer, Corp. Secretary

		
	 Address:
	 	 12851 Worldgate Drive

	 	 	 Herndon, VA 20170

	 Attention:
	 	 Nancy Lysinger

	 Facsimile:
	 	 (703) 234-8315

  
 Signature
Page to Amended and Restated Investor Rights Agreement 

			
	WCAS INVESTORS:
	
	 WELSH, CARSON, ANDERSON
& STOWE VIII, L.P.

	 By WCAS VIII Associates LLC,
General Partner

		
	 By
	 	 /s/ Jonathan M. Rather

	 Name: Jonathan M. Rather

	 Title: Managing Member

			
		
	 Address:
	 	320 Park Avenue, Suite 2500
	 	 	 New York, NY 10022

	 Attention:
	 	Mr. John D. Clark
	 Facsimile:
	 	(212) 893-9575

  

			
	 WELSH, CARSON, ANDERSON &
STOWE VII, L.P.

	 By WCAS VII Partners L.P.,
General Partner

		
	 By:
	 	 /s/ Jonathan M. Rather

	 	 	General Partner

  

			
	 WELSH, CARSON, ANDERSON &
STOWE VI, L.P.

	 By WCAS VI Partners L.P.,
General Partner

		
	 By:
	 	 /s/ Jonathan M. Rather

	 	 	General Partner

			
		
	 Address:
	 	320 Park Avenue, Suite 2500
	 	 	New York, NY 10022
	 Attention:
	 	Mr. Jonathan M. Rather
	 Facsimile:
	 	(212) 893-9575

  
 Signature
Page to Amended and Restated Investor Rights Agreement 

			
	 WCAS MANAGEMENT CORPORATION

		
	 By:
	 	 /s/ Jonathan M. Rather

	 Jonathan M. Rather
 Treasurer

			
		
	 Address:
	 	 320 Park Avenue, Suite 2500

	 	 	 New York, NY 10022

	 Attention:
	 	 Mr. Jonathan M. Rather

	 Facsimile:
	 	 (212) 893-9575

	
	 Patrick J. Welsh

	 Russell Carson

	 Bruce K. Anderson

	 IRA FBO Bruce K. Anderson

	 Thomas E. McInerney

	 Andrew Paul

	 Robert A. Minicucci

	 Anthony J. De Nicola

	 Paul B. Queally

	 D. Scott Mackesy

	 Sanjay Swani

	 IRA FBO James R. Matthews

	 Sean Traynor

	 John Almeida

	 Eric J. Lee

	 IRA FBO Jonathan M. Rather

	 James Hoover

	 Richard Stowe

	 Laura Van Buren

			
		
	 By:
	 	 /s/ Jonathan M. Rather

	 Jonathan M. Rather
 Individually and as Attorney-in-Fact

			
		
	 Address:
	 	 320 Park Avenue, Suite 2500

	 	 	 New York, NY 10022

	 Attention:
	 	 Mr. Jonathan M. Rather

	 Facsimile:
	 	 (212) 893-9575

  
 Signature
Page to Amended and Restated Investor Rights Agreement 

			
	 DANIEL ANDERSON TRUST

		
	 By:
	 	 /s/ Patrick J. Welsh

	 Name: Patrick J. Welsh

	 Title: Trustee

			
		
	 Address:
	 	 c/o Welsh, Carson,

	 	 	 Anderson & Stowe

	 	 	 320 Park Avenue, Suite 2500

	 	 	 New York, NY 10022

	 Attention:
	 	 Mr. Jonathan M. Rather

	 Facsimile:
	 	 (212) 893-9575

			
	
	 KRISTEN ANDERSON TRUST

		
	 By:
	 	 /s/ Patrick J. Welsh

	 Name: Patrick J. Welsh

	 Title: Trustee

			
		
	 Address:
	 	 c/o Welsh, Carson,

	 	 	 Anderson & Stowe

	 	 	 320 Park Avenue, Suite 2500

	 	 	 New York, NY 10022

	 Attention:
	 	 Mr. Jonathan M. Rather

	 Facsimile:
	 	 (212) 893-9575

			
	
	 MARK ANDERSON TRUST

		
	 By:
	 	 /s/ Patrick J. Welsh

	 Name: Patrick J. Welsh

	 Title: Trustee

			
		
	 Address:
	 	 c/o Welsh, Carson,

	 	 	 Anderson & Stowe

	 	 	 320 Park Avenue, Suite 2500

	 	 	 New York, NY 10022

	 Attention:
	 	 Mr. Jonathan M. Rather

	 Facsimile:
	 	 (212) 893-9575

  
 Signature
Page to Amended and Restated Investor Rights Agreement 

			
	OTHER INVESTORS:
	
	 OAK HILL SPECIAL OPPORTUNITIES
FUND, L.P.

	
	 By: Oak Hill Special Opportunities GenPar, L.P.,
its General Partner

	
	 By: Oak Hill Special Opportunities MGP, LLC,
its General Partner

		
	 By
	 	 /s/ William Bohnsack

	 	 	Name: William Bohnsack
	 	 	Title: Managing Director

			
		
	 Address:
	 	 201 Main Street, Suite 1910
 Fort Worth, TX
76034

			
	 Attention: 
	 	Chuck Irwin
	 Facsimile:
	 	(817) 339-7418
	
	 OAK HILL SPECIAL OPPORTUNITIES

	 FUND (MANAGEMENT), L.P.

	
	 By: Oak Hill Special Opportunities GenPar, L.P.,
its General Partner

	
	 By: Oak Hill Special Opportunities MGP, LLC,
its General Partner

	 
	By	 	 /s/ William Bohnsack

	 	 	Name: William Bohnsack
	 	 	Title: Managing Director

			
		
	 Address:
	 	 201 Main Street, Suite 1910
 Fort Worth, TX 76034

	 Attention: 
	 	Chuck Irwin
	 Facsimile:
	 	(817) 339-7418

  
 Signature
Page to Amended and Restated Investor Rights Agreement 

			
	 WFC HOLDINGS CORPORATION

		
	 By
	 	 /s/ Mike Johnson

	 	 	 Name: Mike Johnson

	 	 	 Title: EVP, Attorney in Fact

			
		
	 Address:
	 	 555 Montgomery Street, 77th Floor
 San Francisco, CA
94111

			
	 Attention:
	 	Mike Johnson
	 Facsimile:
	 	(415) 391-2971
	
	 OAK HILL SECURITIES FUND, L.P.

		
	 By:
	 	 Oak Hill Securities Gen Par, L.P.

	 	 	 its General Partner

		
	 By:
	 	 Oak Hill Securities MGP, Inc.,

	 	 	 its General Partner

		
	 By:
	 	 /s/ William Bohnsack

	 	 	Name: William Bohnsack
	 	 	Title: COO

			
		
	 Address:
	 	 201 Main Street, Suite 2600
 Fort Worth, TX
76102

	 Attention:
	 	Chuck Irwin
	 Facsimile: (817) 339-7418

  
 Signature
Page to Amended and Restated Investor Rights Agreement 

			
	 OAK HILL SECURITIES FUND II, L.P.

		
	 By:
	 	 Oak Hill Securities Gen Par II, L.P.
 its General Partner

		
	 By:
	 	 Oak Hill Securities MGP II, Inc.,
 its General Partner

		
	 By:
	 	 /s/ William Bohnsack

	 	 	 Name: William Bohnsack

	 	 	 Title: COO

			
		
	 Address:
	 	 201 Main Street, Suite 2600
 Fort Worth, TX 76102

	 Attention:
	 	 Chuck Irwin

	 Facsimile:
	 	 (817) 339-7418

			
	
	 LERNER ENTERPRISES, L.P.

		
	 By:
	 	 Oak Hill Asset Management, Inc.
 As advisor and attorney-in-fact to
 Lerner Enterprises, L.P.

		
	 By:
	 	 /s/ William Bohnsack

	 	 	 Name: William Bohnsack

	 	 	 Title: COO

			
		
	 Address:
	 	 c/o Oak Hill Asset Management, Inc.
 65 East 55th Street – 32nd Floor
 New York, NY 10022

	 Attention:
	 	 Megan McCann

	 Facsimile:
	 	(212) 593-3596

  
 Signature
Page to Amended and Restated Investor Rights Agreement 

			
	 P&PK FAMILY LTD. PARTNERSHIP

		
	 By:
	 	 Oak Hill Asset Management, Inc.
 As advisor and attorney-in-fact to
 P&PK Family Ltd Partnership

		
	 By:
	 	 /s/ William Bohnsack

	 	 	 Name: William Bohnsack

	 	 	 Title: COO

			
		
	 Address:
	 	 c/o Oak Hill Capital Management, Inc.
 65 East 55th Street – 32nd Floor
 New York, NY 10022

	 Attention:
	 	 Megan McCann

	 Facsimile:
	 	(212) 593-3596

			
	
	 CARDINAL INVESTMENT PARTNERS I, L.P.

		
	 By:
	 	 Oak Hill Asset Management, Inc.
 As advisor and attorney-in-fact to
 Cardinal Investment Partners I, L.P.

		
	 By:
	 	 /s/ William Bohnsack

	 	 	 Name: William Bohnsack

	 	 	 Title: COO

			
		
	 Address:
	 	 201 Main Street, 24th Floor
 Fort Worth, TX 76102

	 Attention:
	 	 Ray Pinson

	 Facsimile:
	 	 (817) 339-7350

  
 Signature
Page to Amended and Restated Investor Rights Agreement 

			
	 OAK HILL CREDIT ALPHA FUND, L.P.

		
	 By:
	 	 Oak Hill Credit Alpha Gen Par, L.P.
 its General Partner

		
	 By:
	 	 Oak Hill Credit Alpha MGP, Inc.,
 its General Partner

		
	 By:
	 	 /s/ William Bohnsack

	 	 	 Name: William Bohnsack

	 	 	 Title: COO

			
		
	 Address:
	 	 201 Main Street, Suite 1910
 Fort Worth, TX 76102

	 Attention:
	 	 P. Joseph Driggers

	 Facsimile:
	 	 (817) 339-7418

			
	
	 OAK HILL CREDIT ALPHA FUND (OFFSHORE), LTD.

		
	 By:
	 	 /s/ William Bohnsack

	 	 	 Name: William Bohnsack

	 	 	 Title: COO

			
		
	 Address:
	 	 201 Main Street, Suite 1910
 Fort Worth, TX 76102

	 Attention:
	 	 P. Joseph Driggers

	 Facsimile:
	 	 (817) 339-7418

  
 Signature
Page to Amended and Restated Investor Rights Agreement 

			
	 OAK HILL ADVISORS, L.P.
 as Investment Manager for
 The Leland Stanford Junior University

		
	 By:
	 	 Oak Hill Advisors MGP, Inc.
 its Managing General Partner

		
	 By:
	 	 /s/ William Bohnsack

	 	 	 Name: William Bohnsack

	 	 	 Title: COO

			
		
	 Address:
	 	 The Leland Stanford Jr. University
 c/o Oak Hill Capital Management, Inc.
 65 East 55th Street - 32nd Floor
 New York, NY 10022

	 Attention:
	 	 Megan McCann

	 Facsimile:
	 	 (212) 593-3596

			
	
	 CARDINAL FUND I, L.P.

	
	 By: Cardinal Management I, L.P.,
its General Partner

	
	 By: Cardinal MGP, LLC,
its General Partner

		
	 By
	 	 /s/ John H. Fant

	 	 	 Name: John H. Fant

	 	 	 Title: Vice President

			
		
	 Address:
	 	 201 Main Street, Suite 2415

	 	 	 Fort Worth, Texas 76102

	 Attention:
	 	 Ray L. Pinson

	 Facsimile:
	 	 (817) 339-7350

  
 Signature
Page to Amended and Restated Investor Rights Agreement 

			
	 FW SAVVIS INVESTORS, L.P.

	
	 By: Group VI 31, L.L.C.,
its General Partner

		
	 By
	 	 /s/ John H. Fant

	 	 	 Name: John H. Fant

	 	 	 Title:   Vice President

			
		
	 Address:
	 	 201 Main Street, Suite 3100

	 	 	 Fort Worth, Texas 76102

	 Attention:
	 	 John H. Fant

	 Facsimile:
	 	 (817) 820-1621

  
 Signature
Page to Amended and Restated Investor Rights Agreement 

			
	CONSTELLATION VENTURE CAPITAL II, L.P.
		
	 By:
	 	 Constellation Ventures Management, L.L.C.,
its General Partner

		
	 By:
	 	 The Bear Stearns Companies, Inc.,
its Managing Member

		
	 By:
	 	 /s/ Clifford H. Friedman

	 	 	 Name: Clifford H. Friedman

	 	 	 Title: SMD

					
		
	 Address:
	 	 383 Madison Avenue, 28th Floor
 New York, NY
10179

	 Attention:
	 	 Clifford H. Friedman

	 Facsimile:
	 	 (212) 272-9256

			
	
	CONSTELLATION VENTURE CAPITAL OFFSHORE II, L.P.
		
	 By:
	 	 Constellation Ventures Management, L.L.C.,
its General Partner

		
	 By:
	 	 The Bear Stearns Companies, Inc.,
its Managing Member

		
	 By:
	 	 /s/ Clifford H. Friedman

	 	 	 Name: Clifford H. Friedman

	 	 	 Title: SMD

					
		
	 Address:
	 	 383 Madison Avenue, 28th Floor
 New York, NY
10179

	 Attention:
	 	 Clifford H. Friedman

	 Facsimile:
	 	 (212) 272-9256

  
 Signature
Page to Amended and Restated Investor Rights Agreement 

			
	 THE BSC EMPLOYEE FUND IV, L.P.

		
	 By:
	 	 Constellation Ventures Management, L.L.C.,
its General Partner

		
	 By:
	 	 The BSCGP, Inc.,
its Managing Member

		
	 By:
	 	 /s/ Clifford H. Friedman

	 	 	 Name: Clifford H. Friedman

	 	 	 Title: SMD

					
		
	 Address:
	 	 383 Madison Avenue, 28th Floor
 New York, NY
10179

	 Attention:
	 	 Clifford H. Friedman

	 Facsimile:
	 	 (212) 272-9256

			
	
	 CVC II PARTNERS, L.L.C.

		
	 By:
	 	 /s/ Clifford H. Friedman

	 	 	 Name: Clifford H. Friedman

	 	 	 Title: SMD

					
		
	 Address:
	 	 383 Madison Avenue, 28th Floor
 New York, NY
10179

	 Attention:
	 	 Clifford H. Friedman

	 Facsimile:
	 	 (212) 272-9256

  
 Signature
Page to Amended and Restated Investor Rights Agreement 

 [INSERT SIGNATURE BLOCKS FOR ANY OTHER INVESTORS THAT BECOME A PARTY TO THIS AGREEMENT] 
  
 Signature Page to Amended and Restated Investor Rights Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00061-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00061-of-00352.parquet"}]]